Document and Entity Information
Document and Entity Information | 9 Months Ended |
Sep. 30, 2021shares | |
Cover | |
Document Type | 10-Q |
Document Quarterly Report | true |
Document Transition Report | false |
Document Period End Date | Sep. 30, 2021 |
Entity File Number | 1-9576 |
Entity Registrant Name | O-I GLASS, INC. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 22-2781933 |
Entity Address, Address Line One | One Michael Owens Way |
Entity Address, City or Town | Perrysburg |
Entity Address, State or Province | OH |
Entity Address, Postal Zip Code | 43551 |
City Area Code | 567 |
Local Phone Number | 336-5000 |
Title of 12(b) Security | Common Stock, $.01 par value |
Security Exchange Name | NYSE |
Trading Symbol | OI |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Small Business | false |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 156,827,223 |
Entity Central Index Key | 0000812074 |
Amendment Flag | false |
Document Fiscal Year Focus | 2021 |
Current Fiscal Year End Date | --12-31 |
Document Fiscal Period Focus | Q3 |
CONDENSED CONSOLIDATED RESULTS
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS | ||||
Net sales | $ 1,609 | $ 1,616 | $ 4,770 | $ 4,595 |
Revenue, Product and Service [Extensible List] | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember | us-gaap:ProductMember |
Cost of goods sold | $ (1,307) | $ (1,339) | $ (3,916) | $ (3,887) |
Gross profit | 302 | 277 | 854 | 708 |
Selling and administrative expense | (108) | (95) | (325) | (308) |
Research, development and engineering expense | (19) | (16) | (57) | (45) |
Interest expense, net | (50) | (61) | (153) | (212) |
Equity earnings | 23 | 21 | 64 | 49 |
Other income (expense), net | (21) | 250 | (123) | 147 |
Earnings from continuing operations before income taxes | 127 | 376 | 260 | 339 |
Provision for income taxes | (43) | (41) | (144) | (50) |
Earnings from continuing operations | 84 | 335 | 116 | 289 |
Gain from discontinued operations | 7 | 7 | ||
Net earnings | 91 | 335 | 123 | 289 |
Net earnings attributable to noncontrolling interests | (6) | (7) | (17) | (11) |
Net earnings attributable to the Company | 85 | 328 | 106 | 278 |
Amounts attributable to the Company: | ||||
Earnings from continuing operations | 78 | 328 | 99 | 278 |
Gain from discontinued operations | 7 | 7 | ||
Net earnings | $ 85 | $ 328 | $ 106 | $ 278 |
Basic earnings per share: | ||||
Earnings from continuing operations attributable to the Company (in dollars per share) | $ 0.49 | $ 2.09 | $ 0.62 | $ 1.77 |
Gain from discontinued operations (in dollars per share) | 0.05 | 0.05 | ||
Net earnings (in dollars per share) | $ 0.54 | $ 2.09 | $ 0.67 | $ 1.77 |
Weighted average shares outstanding (thousands) (in shares) | 156,825 | 157,073 | 157,430 | 156,650 |
Diluted earnings per share: | ||||
Earnings from continuing operations attributable to the Company (in dollars per share) | $ 0.48 | $ 2.06 | $ 0.61 | $ 1.76 |
Gain from discontinued operations (in dollars per share) | 0.05 | 0.05 | ||
Net earnings (in dollars per share) | $ 0.53 | $ 2.06 | $ 0.66 | $ 1.76 |
Weighted average diluted shares outstanding (thousands) (in shares) | 160,511 | 159,299 | 160,473 | 158,438 |
CONDENSED CONSOLIDATED COMPREHE
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (LOSS) | ||||
Net earnings | $ 91 | $ 335 | $ 123 | $ 289 |
Other comprehensive income (loss): | ||||
Foreign currency translation adjustments | (110) | (148) | (81) | (666) |
Pension and other postretirement benefit adjustments, net of tax | 78 | 42 | 115 | 92 |
Change in fair value of derivative instruments, net of tax | 13 | (11) | 26 | (18) |
Other comprehensive income (loss) | (19) | (117) | 60 | (592) |
Total comprehensive income (loss) | 72 | 218 | 183 | (303) |
Comprehensive income attributable to non-controlling interests | (5) | (7) | (3) | (1) |
Comprehensive income (loss) attributable to the Company | $ 67 | $ 211 | $ 180 | $ (304) |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
Current assets: | |||
Cash and cash equivalents | $ 628 | $ 563 | $ 606 |
Trade receivables, net of allowance of $31 million, $33 million, and $33 million at September 30, 2021, December 31, 2020 and September 30, 2020 | 793 | 623 | 724 |
Inventories | 808 | 841 | 782 |
Prepaid expenses and other current assets | 213 | 270 | 272 |
Total current assets | 2,442 | 2,297 | 2,384 |
Property, plant and equipment, net | 2,785 | 2,907 | 2,675 |
Goodwill | 1,879 | 1,951 | 1,847 |
Intangibles, net | 294 | 325 | 311 |
Other assets | 1,366 | 1,402 | 1,407 |
Total assets | 8,766 | 8,882 | 8,624 |
Current liabilities: | |||
Accounts payable | 1,062 | 1,126 | 910 |
Short-term loans and long-term debt due within one year | 79 | 197 | 212 |
Other liabilities | 597 | 575 | 575 |
Total current liabilities | 1,738 | 1,898 | 1,697 |
Long-term debt | 4,853 | 4,945 | 5,163 |
Paddock support agreement liability | 625 | 471 | 471 |
Other long-term liabilities | 980 | 1,167 | 1,028 |
Share owners' equity | 570 | 401 | 265 |
Total liabilities and share owners' equity | $ 8,766 | $ 8,882 | $ 8,624 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
Trade receivables allowance | $ 31 | $ 33 | $ 33 |
CONDENSED CONSOLIDATED CASH FLO
CONDENSED CONSOLIDATED CASH FLOWS - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2020 | |
Cash flows from operating activities: | |||||||
Net earnings | $ 91 | $ 335 | $ 123 | $ 289 | |||
Gain from discontinued operations | (7) | (7) | |||||
Non-cash charges | |||||||
Depreciation and amortization | 349 | 363 | |||||
Pension expense | 24 | 30 | |||||
Charge related to Paddock support agreement liability | $ 154 | 154 | |||||
Brazil indirect tax credit | (69) | ||||||
Restructuring, asset impairment and related charges | 12 | 5 | 20 | 72 | |||
Pension settlement charges | 5 | 8 | |||||
Gain on sale of ANZ business | (280) | (280) | |||||
Cash payments | |||||||
Pension contributions | (33) | (32) | |||||
Cash paid for restructuring activities | (5) | (10) | (14) | (32) | |||
Change in components of working capital | (139) | (402) | |||||
Other, net (a) | 36 | 112 | |||||
Cash provided by continuing operating activities | 449 | 128 | |||||
Cash provided by discontinued operating activities | 7 | ||||||
Cash provided by operating activities | 456 | 128 | |||||
Cash flows from investing activities: | |||||||
Cash payments for property, plant and equipment | (268) | (246) | |||||
Cash proceeds on disposal of other businesses and misc. assets | 8 | 2 | |||||
Cash proceeds on sale of ANZ businesses, net of transaction costs | 58 | 441 | |||||
Deconsolidation of Paddock | $ (47) | (47) | |||||
Other | 1 | ||||||
Cash provided by (utilized in) investing activities | (202) | 151 | |||||
Cash flows from financing activities: | |||||||
Changes in borrowings, net | (119) | (300) | |||||
Payment of finance fees | (50) | ||||||
Shares repurchased | (30) | ||||||
Dividends paid | (8) | ||||||
Net cash proceeds (payments) for hedging activity | (10) | (8) | |||||
Sale leaseback proceeds in conjunction with ANZ sale | 155 | ||||||
Distributions to non-controlling interests | (10) | (5) | |||||
Other, net | (2) | (3) | |||||
Cash utilized in financing activities | (171) | (219) | |||||
Effect of exchange rate fluctuations on cash | (18) | (5) | |||||
Change in cash | 65 | 55 | |||||
Cash at beginning of period | $ 563 | $ 551 | 563 | 551 | $ 551 | ||
Cash at end of period | $ 628 | $ 606 | $ 628 | $ 606 | $ 563 |
Segment Information
Segment Information | 9 Months Ended |
Sep. 30, 2021 | |
Segment Information | |
Segment Information | 1. Segment Information Historically, the Company had three reportable segments and three operating segments based on its geographic locations: the Americas, Europe and Asia Pacific. These three segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. On July 31, 2020, the Company completed the sale of its Australia and New Zealand (“ANZ”) businesses, which comprised the majority of its businesses in the Asia Pacific region (approximately 85% of net sales in that region for the full year 2019), to Visy Industries Holdings Pty Ltd. (“Visy”). After the sale of the ANZ businesses, the remaining businesses in the Asia Pacific region do not meet the criteria of an individually reportable segment. For the three and nine months ended September 30, 2020, the results of the Asia Pacific segment reflect only the results of its ANZ businesses. For all historical periods discussed in this report, the sales and operating results of the other businesses that historically comprised the Asia Pacific segment, and that have been retained by the Company, have been reclassified to Other sales and Retained corporate costs and other, respectively. For asset reporting purposes, only the assets related to the ANZ businesses have been reported in the Asia Pacific segment, while the other businesses that historically comprised this segment and that have been retained by the Company have been reclassified to the Other assets line for all periods presented. Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, certain equity investments and the remaining businesses in the Asia Pacific region that do not meet the criteria of an individually reportable segment after the sale of the ANZ businesses. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments. The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings (loss) before interest income, interest expense, and benefit (provision) for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations, as well as certain retained corporate costs. The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under U.S. GAAP and, therefore, does not purport to be an alternative to earnings (loss) before income taxes. Further, the Company's measure of segment operating profit may not be comparable to similarly titled measures of other companies. Financial information for the three and nine months ended September 30, 2021 and 2020 regarding the Company’s reportable segments is as follows: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Net sales: Americas $ 925 $ 887 $ 2,652 $ 2,442 Europe 655 644 2,039 1,775 Asia Pacific 52 281 Reportable segment totals 1,580 1,583 4,691 4,498 Other 29 33 79 97 Net sales $ 1,609 $ 1,616 $ 4,770 $ 4,595 Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Segment operating profit: Americas $ 133 $ 113 $ 357 $ 268 Europe 110 88 293 191 Asia Pacific 3 19 Reportable segment totals 243 204 650 478 Items excluded from segment operating profit: Retained corporate costs and other (49) (35) (126) (98) Gain on sale of ANZ businesses 280 280 Brazil indirect tax credit 69 Restructuring, asset impairment and other charges (12) (9) (21) (80) Charge related to Paddock support agreement liability (154) Charge for deconsolidation of Paddock (14) Pension settlement charges (5) (5) (8) Strategic transaction costs (3) (7) Interest expense, net (50) (61) (153) (212) Earnings from continuing operations before income taxes $ 127 $ 376 $ 260 $ 339 Financial information regarding the Company’s total assets is as follows: September 30, December 31, September 30, 2021 2020 2020 Total assets: Americas $ 4,925 $ 4,927 $ 4,663 Europe 3,457 3,507 3,307 Reportable segment totals 8,382 8,434 7,970 Other 384 448 654 Consolidated totals $ 8,766 $ 8,882 $ 8,624 |
Revenue
Revenue | 9 Months Ended |
Sep. 30, 2021 | |
Revenue | |
Revenue | 2. Revenue Revenue is recognized at the point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment. For the three- and nine-month periods ended September 30, 2021 and September 30, 2020, the Company had no material bad debt expense, and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Condensed Consolidated Balance Sheet. Consistent with the disclosures in Note 1 related to the ANZ sale, Asia Pacific revenue for the three- and nine-month periods ended September 30, 2020, reflect only the revenue of the ANZ businesses. The other businesses that comprised the Asia Pacific segment and that have been retained by the Company have been reclassified to the Other sales line. The following tables for the three months ended September 30, 2021 and 2020 disaggregate the Company’s revenue by customer end use: Three months ended September 30, 2021 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 561 $ 467 $ — $ 1,028 Food and other 215 124 339 Non-alcoholic beverages 149 64 213 Reportable segment totals $ 925 $ 655 $ — $ 1,580 Other 29 Net sales $ 1,609 Three months ended September 30, 2020 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 537 $ 452 $ 40 $ 1,029 Food and other 222 138 6 366 Non-alcoholic beverages 128 54 6 188 Reportable segment totals $ 887 $ 644 $ 52 $ 1,583 Other 33 Net sales $ 1,616 The following tables for the nine months ended September 30, 2021 and 2020 disaggregate the Company’s revenue by customer end use: Nine months ended September 30, 2021 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 1,610 $ 1,507 $ — $ 3,117 Food and other 627 366 993 Non-alcoholic beverages 415 166 581 Reportable segment totals $ 2,652 $ 2,039 $ — $ 4,691 Other 79 Net sales $ 4,770 Nine months ended September 30, 2020 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 1,471 $ 1,258 $ 217 $ 2,946 Food and other 609 360 38 1,007 Non-alcoholic beverages 362 157 26 545 Reportable segment totals $ 2,442 $ 1,775 $ 281 $ 4,498 Other 97 Net sales $ 4,595 |
Credit Losses
Credit Losses | 9 Months Ended |
Sep. 30, 2021 | |
Credit Losses | |
Credit Losses | 3. Credit Losses The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers it sells to them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness, based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue the recovery of defaulted receivables. At September 30, 2021 and September 30, 2020, the Company reported $793 million and $724 million of accounts receivable, respectively, net of allowances of $31 million and $33 million, respectively. Changes in the allowance were not material for each of the three and nine months ended September 30, 2021 and September 30, 2020. |
Inventories
Inventories | 9 Months Ended |
Sep. 30, 2021 | |
Inventories | |
Inventories | 4. Inventories Major classes of inventory at September 30, 2021, December 31, 2020 and September 30, 2020 are as follows: September 30, December 31, September 30, 2021 2020 2020 Finished goods $ 651 $ 675 $ 625 Raw materials 120 129 121 Operating supplies 37 37 36 $ 808 $ 841 $ 782 |
Derivative Instruments
Derivative Instruments | 9 Months Ended |
Sep. 30, 2021 | |
Derivative Instruments | |
Derivative Instruments | 5. Derivative Instruments The Company has certain derivative assets and liabilities, which consist of foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs are observable in active markets over the terms of the instruments the Company holds, and, accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy. Cash Flow Hedges of Foreign Exchange Risk The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency. The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign exchange risk. An unrecognized gain of $9 million at September 30, 2021, an unrecognized gain of $9 million at December 31, 2020 and an unrecognized gain of $9 million at September 30, 2020, related to these cross-currency swaps, were included in Accumulated OCI, and will be reclassified into earnings within the next 12 months. Interest Rate Swaps Designated as Fair Value Hedges The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. The Company’s fixed-to-variable interest rate swaps are accounted for as fair value hedges. The relevant terms of the swap agreements match the corresponding terms of the notes, and therefore there is no hedge ineffectiveness. The Company recorded the net of the fair market values of the swaps as a long-term liability and short-term asset, along with a corresponding net decrease in the carrying value of the hedged debt. Cash Flow Hedges of Interest Rate Risk The Company enters into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt. An unrecognized loss of $0 at September 30, 2021, an unrecognized loss of less than $1 million at December 31, 2020 and an unrecognized loss of less than $1 million at September 30, 2020 related to these interest rate swaps were included in Accumulated OCI and will be reclassified into earnings within the next 12 months. Net Investment Hedges The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure. Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies. Balance Sheet Classification The following table shows the amount and classification (as noted above) of the Company’s derivatives at September 30, 2021, December 31, 2020 and September 30, 2020: Fair Value of Fair Value of Hedge Assets Hedge Liabilities September 30, December 31, September 30, September 30, December 31, September 30, 2021 2020 2020 2021 2020 2020 Derivatives designated as hedging instruments: Interest rate swaps - fair value hedges (a) $ 9 $ 17 $ 16 $ 1 $ — $ — Cash flow hedges of foreign exchange risk (b) 9 6 9 54 115 67 Net investment hedges (c) 2 1 2 28 52 27 Total derivatives accounted for as hedges $ 20 $ 24 $ 27 $ 83 $ 167 $ 94 Derivatives not designated as hedges: Foreign exchange derivative contracts (d) 1 1 3 4 3 6 Total derivatives $ 21 $ 25 $ 30 $ 87 $ 170 $ 100 Current $ 15 $ 13 $ 16 $ 4 $ 15 $ 13 Noncurrent 6 12 14 83 155 87 Total derivatives $ 21 $ 25 $ 30 $ 87 $ 170 $ 100 (a) The notional amounts of the interest rate swaps designated as fair value hedges were €725 million at September 30, 2021, December 31, 2020 and September 30, 2020. The maximum maturity dates were in 2024 for all three periods. (b) The notional amounts of the cash flow hedges of foreign exchange risk were $878 million at September 30, 2021, $978 million at December 31, 2020 and $1.1 billion at September 30, 2020. The maximum maturity dates were in 2023 for all three periods. (c) The notional amounts of the net investment hedges were €311 million at September 30, 2021, €311 million at December 31, 2020 and €311 million at September 30, 2020. The maximum maturity dates were in 2027 for September 30, 2021 and December 31, 2020 and in 2020 for September 30, 2020. (d) The notional amounts of the foreign exchange derivative contracts were $291 million, $247 million and $247 million at September 30, 2021, December 31, 2020 and September 30, 2020, respectively. The maximum maturity dates were in 2021 for all three periods. Gain (Loss) Recognized in OCI (Effective Portion) Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) Three months ended September 30, Three months ended September 30, Derivatives designated as hedging instruments: 2021 2020 2021 2020 Cash Flow Hedges Cash flow hedges of foreign exchange risk (a) $ 24 $ (61) $ 24 $ (80) Cash flow hedges of interest rate risk (b) Net Investment Hedges Net Investment Hedges (b) 13 (26) 1 1 $ 37 $ (87) $ 25 $ (79) Gain (Loss) Recognized in OCI (Effective Portion) Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) Nine months ended September 30, Nine months ended September 30, Derivatives designated as hedging instruments: 2021 2020 2021 2020 Cash Flow Hedges Cash flow hedges of foreign exchange risk (a) $ 56 $ (51) $ 57 $ (71) Cash flow hedges of interest rate risk (b) (1) Net Investment Hedges Net Investment Hedges (b) 27 (29) 2 4 $ 83 $ (80) $ 59 $ (68) Amount of Gain (Loss) Recognized in Other income (expense), net Amount of Gain (Loss) Recognized in Other income (expense), net Three months ended September 30, Nine months ended September 30, Derivatives not designated as hedges: 2021 2020 2021 2020 Foreign exchange derivative contracts $ 2 $ 3 $ 9 $ 13 (1) Gains and losses reclassified from accumulated OCI and recognized in income are recorded to (a) other income (expense), net or (b) interest expense, net. |
Restructuring Accruals
Restructuring Accruals | 9 Months Ended |
Sep. 30, 2021 | |
Restructuring Accruals | |
Restructuring Accruals | 6 . Restructuring Accruals Selected information related to the restructuring accruals for the three months ended September 30, 2021 and 2020 is as follows: Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at July 1, 2021 $ 32 $ — $ 12 $ 44 Charges 1 11 12 Write-down of assets to net realizable value (1) (1) Net cash paid, principally severance and related benefits (4) (1) (5) Other, including foreign exchange translation — Balance at September 30, 2021 $ 28 $ — $ 22 $ 50 Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at July 1, 2020 $ 30 $ — $ 17 $ 47 Charges 2 3 5 Write-down of assets to net realizable value (3) (3) Net cash paid, principally severance and related benefits (10) (10) Other, including foreign exchange translation (4) (4) Balance at September 30, 2020 $ 22 $ — $ 13 $ 35 Selected information related to the restructuring accruals for the nine months ended September 30, 2021 and 2020 is as follows: Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2021 $ 38 $ — $ 7 $ 45 Charges 2 1 17 20 Write-down of assets to net realizable value (1) (1) Net cash paid, principally severance and related benefits (11) (3) (14) Other, including foreign exchange translation (1) 1 — Balance at September 30, 2021 $ 28 $ — $ 22 $ 50 Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2020 $ 32 $ $ 13 $ 45 Charges 23 43 6 72 Write-down of assets to net realizable value (43) (43) Net cash paid, principally severance and related benefits (31) (1) (32) Other, including foreign exchange translation (2) (5) (7) Balance at September 30, 2020 $ 22 $ — $ 13 $ 35 When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the on-going operations of the business. Information related to major programs is presented separately, while minor initiatives are presented on a combined basis. As of September 30, 2021 and 2020, no major restructuring programs were in effect. For the three and nine months ended September 30, 2021, the Company implemented several discrete restructuring initiatives and recorded restructuring and other charges of $12 million and $20 million, respectively. These charges consisted of employee costs, such as severance and benefit-related costs and other exit costs (including related consulting costs attributed to restructuring of managed services activities) at a number of the Company’s businesses in the Americas and Europe. These restructuring charges were discrete actions and are expected to approximate the total cumulative costs for those actions as no material additional costs are expected to be incurred. For the three and nine months ended September 30, 2021, these charges were recorded to Other income (expense), net on the Condensed Consolidated Results of Operations. The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years. For the three and nine months ended September 30, 2020, the Company implemented several discrete restructuring initiatives and recorded restructuring, asset impairment and other charges of $5 million and $72 million, respectively. These charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs, primarily related to a plant closure in the Americas and to a reduction-in-force program as part of its selling, general and administrative expense reduction initiative to help simplify the organization and improve decision making and execution. These restructuring charges were discrete actions and are expected to approximate the total cumulative costs for those actions as no material additional costs are expected to be incurred. For the three and nine months ended September 30, 2020, these charges were recorded to Other income (expense), net on the Condensed Consolidated Results of Operations. The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years. The Company’s decisions to curtail selected production capacity have resulted in write-downs of certain long-lived assets to the extent their carrying value exceeded fair value or fair value less cost to sell. The Company classified the assumptions used to determine the fair value of the impaired assets in the period that the measurement was taken as Level 3 (third-party appraisal) in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. For the asset impairments recorded through September 30, 2021, the remaining carrying value of the impaired assets was approximately $1 million. |
Pension Benefit Plans
Pension Benefit Plans | 9 Months Ended |
Sep. 30, 2021 | |
Pension Benefit Plans | |
Pension Benefit Plans | 7. Pension Benefit Plans The components of the net periodic pension cost for the three months ended September 30, 2021 and 2020 are as follows: U.S. Non-U.S. 2021 2020 2021 2020 Service cost $ 3 $ 3 $ 3 $ 3 Interest cost 10 12 5 6 Expected asset return (21) (19) (11) (12) Amortization of actuarial loss 16 14 3 3 Net periodic pension cost $ 8 $ 10 $ — $ — The components of the net periodic pension cost for the nine months ended September 30, 2021 and 2020 are as follows: U.S. Non-U.S. 2021 2020 2021 2020 Service cost $ 9 $ 9 $ 9 $ 10 Interest cost 30 37 15 19 Expected asset return (63) (60) (34) (36) Amortization of actuarial loss 48 42 10 9 Net periodic pension cost $ 24 $ 28 $ — $ 2 The components of pension expense, other than the service cost component, are included in Other income (expense), net on the Condensed Consolidated Results of Operations. The Company settled a portion of its pension obligations, which resulted in a reduction of its pension liability of approximately $46 million and pension settlement charges of $5 million in both the three and nine months ended September 30, 2021. For the three and nine months ended September 30, 2020, the Company recorded pension settlement charges totaling During the third quarter of 2020, the Company remeasured a portion of its post-retirement benefit obligations in the U.S. due to plan changes, which resulted in a reduction in post-retirement benefit obligations of approximately $32 million. |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2021 | |
Income Taxes. | |
Income Taxes | 8. Income Taxes The Company calculates its interim tax provision using the estimated annual effective tax rate (“EAETR”) methodology in accordance with ASC 740-270. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income or loss in each tax jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the quarter they occur, in accordance with GAAP. Depending on various factors, such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. The Company’s annual effective tax rate may be affected by the mix of earnings in the U.S. and foreign jurisdictions, and factors such as changes in tax laws, tax rates or regulations, changes in business, changing interpretation of existing tax laws or regulations, the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions. The annual effective tax rate differs from the statutory U.S. Federal tax rate of 21% primarily because of varying non-U.S. tax rates and the impact of the U.S. valuation allowance. The Company is currently under examination in various tax jurisdictions, including Brazil, Canada, Colombia, France, Indonesia, Italy, Mexico and Peru. The years under examination range from 2004 through 2018. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies, such as appeals and litigation, if necessary. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact on the Company’s consolidated results of operations, financial position or cash flows. |
Debt
Debt | 9 Months Ended |
Sep. 30, 2021 | |
Debt | |
Debt | 9. Debt The following table summarizes the long-term debt of the Company: September 30, December 31, September 30, 2021 2020 2020 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ — $ — $ 195 Term Loans: Term Loan A 1,068 1,067 1,157 Other secured debt 99 109 Senior Notes: 4.00%, due 2023 308 307 307 5.875%, due 2023 694 692 691 3.125%, due 2024 (€725 million) 854 914 873 6.375%, due 2025 297 296 296 5.375%, due 2025 298 298 298 2.875%, due 2025 (€500 million) 574 607 579 6.625%, due 2027 693 692 691 Finance leases 99 108 94 Other 5 7 6 Total long-term debt 4,890 5,087 5,296 Less amounts due within one year 37 142 133 Long-term debt $ 4,853 $ 4,945 $ 5,163 The Company presents debt issuance costs in the condensed consolidated balance sheet as a deduction of the carrying amount of the related debt liability. On June 25, 2019, certain of the Company’s subsidiaries entered into a Senior Secured Credit Facility Agreement (as amended by that certain Amendment No. 1 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 13, 2019, and as further amended by that certain Amendment No. 2 to the Third Amended and Restated Credit Agreement and Syndicated Facility Agreement dated as of December 19, 2019, the “Agreement”), which amended and restated the previous credit agreement (the “Previous Agreement”). The proceeds from the Agreement were used to repay all outstanding amounts under the Previous Agreement. The Agreement provides for up to $3.0 billion of borrowings pursuant to term loans and revolving credit facilities. The term loans mature, and the revolving credit facilities terminate, in June 2024. At September 30, 2021, the Agreement includes a million outstanding balance at September 30, 2021, net of debt issuance costs ). At September 30, 2021, the Company had unused credit of The Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations. The Agreement also contains one financial maintenance covenant, a Total Leverage Ratio (the “Leverage Ratio”), that requires the Company not to exceed a ratio of 5.0x calculated by dividing consolidated total debt, less cash and cash equivalents, by Consolidated EBITDA, with such Leverage Ratio decreasing to (a) 4.75x for the quarter ending September 30, 2021 and (b) 4.50 x for the quarter ending December 31, 2021 and thereafter, as defined and described in the Agreement. The maximum Leverage Ratio is subject to an increase of quarters, provided that the Leverage Ratio shall not exceed 5.0x. The Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Leverage Ratio to exceed the specified maximum. Failure to comply with these covenants and other customary restrictions could result in an event of default under the Agreement. In such an event, the Company could not request borrowings under the revolving facilities, and all amounts outstanding under the Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0 % per annum will apply to all overdue obligations under the Agreement. If an event of default occurs under the Agreement and the lenders cause all of the outstanding debt obligations under the Agreement to become due and payable, this would result in a default under the indentures governing the Company’s outstanding debt securities and could lead to an acceleration of obligations related to these debt securities. As of September 30, 2021, the Company was in compliance with all covenants and restrictions in the Agreement. In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the Agreement will not be adversely affected by the covenants and restrictions. The Leverage Ratio also determines pricing under the Agreement. The interest rate on borrowings under the Agreement is, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the Agreement, plus an applicable margin. The applicable margin is linked to the Leverage Ratio. The margins range from for Base Rate Loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from Obligations under the Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Agreement are guaranteed by certain foreign subsidiaries of the Company. In May 2020, the Company issued $700 million aggregate principal amount of senior notes. The senior notes bear interest at a rate of 6.625 % per annum and mature on May 13, 2027. The senior notes were issued via a private placement and are guaranteed by certain of the Company’s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately $690 million and were used to redeem the remaining $130 million aggregate principal amount of the Company’s outstanding 4.875% senior notes due 2021, approximately $419 million aggregate principal amount of the Company’s outstanding 5.00% senior notes due 2022 and approximately $105 million of other secured borrowings. The Company recorded approximately $38 million of additional interest charges for note repurchase premiums and write-off of unamortized finance fees related to these redemptions. In August 2020, the Company redeemed the remaining $81 million aggregate principal amount of the Company’s outstanding 5.00% senior notes due 2022. The Company recorded approximately $6 million of additional interest charges for note repurchase premiums and write-off of unamortized finance fees related to this redemption. In order to maintain a capital structure containing appropriate amounts of fixed and floating-rate debt, the Company has entered into a series of interest rate swap agreements. These interest rate swap agreements were accounted for as either fair value hedges or cash flow hedges (see Note 5 for more information). The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market. The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy. Fair values at September 30, 2021 of the Company’s significant fixed rate debt obligations are as follows: Principal Indicated Market Amount Price Per $ Fair Value Senior Notes: 5.875%, due 2023 $ 700 $ 106.00 $ 742 4.00%, due 2023 310 102.57 318 3.125%, due 2024 (€725 million) 841 103.53 871 6.375%, due 2025 300 110.86 333 5.375%, due 2025 300 107.11 321 2.875%, due 2025 (€500 million) 580 101.56 589 6.625%, due 2027 700 107.40 752 |
Contingencies
Contingencies | 9 Months Ended |
Sep. 30, 2021 | |
Contingencies | |
Contingencies | 10 . Contingencies Asbestos From 1948 to 1958, one of the Company's former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos. The Company sold its insulation business unit in April 1958. The Company historically received claims from individuals alleging bodily injury and death as a result of exposure to asbestos from this product (“Asbestos Claims”). Some Asbestos Claims were brought as personal injury lawsuits that typically allege various theories of liability, including negligence, gross negligence and strict liability and seek compensatory and, in some cases, punitive damages. Predominantly, however, Asbestos Claims were historically presented to the Company under administrative claims-handling agreements, which the Company had in place with many plaintiffs’ counsel throughout the country (“Administrative Claims”). Administrative Claims required evaluation and negotiation regarding whether particular claimants qualify under the criteria established by the related claims-handling agreements. The criteria for Administrative Claims included verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company's former business unit during its manufacturing period ending in 1958. Plaintiffs’ counsel presented, and the Company negotiated, Administrative Claims under these various agreements in differing quantities, at different times, and under a variety of conditions. On December 26 and 27, 2019, the Company implemented the Corporate Modernization, whereby O-I Glass became the new parent entity with Owens-Illinois Group, Inc. (“O-I Group”) and Paddock Enterprises LLC (“Paddock”) as direct, wholly owned subsidiaries, with Paddock as the successor-by-merger to O-I. The Company’s legacy asbestos-related liabilities remained within Paddock, with the Company’s glass-making operations remaining under O-I Group. As part of the Corporate Modernization transactions, O-I Glass entered into a support agreement with Paddock that requires O-I Glass to provide funding to Paddock for all permitted uses, subject to the terms of the support agreement. The key objectives of the Paddock support agreement are to ensure that Paddock has the ability to fund the costs and expenses of managing the Chapter 11 process, and ultimately settle Asbestos Claims through the establishment of a trust as described below and fund certain other liabilities. On January 6, 2020 (the “Petition Date”), Paddock voluntarily filed for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) to equitably and finally resolve all of its current and future asbestos-related claims. O-I Glass and O-I Group were not included in the Chapter 11 filing. As a result of the initiation of the Chapter 11 proceeding, Paddock continues to operate in the ordinary course and with court protection from Asbestos Claims by operation of the automatic stay in Paddock’s Chapter 11 filing, which stays ongoing litigation and submission of claims against Paddock outside the Bankruptcy Court as of the Petition Date and defers the payment of Paddock’s outstanding obligations on account of settled or otherwise determined lawsuits and claims. The bankruptcy process is expected to provide a centralized forum to resolve presently pending and anticipated future lawsuits and claims associated with asbestos. Paddock’s ultimate goal in its Chapter 11 case is to confirm a plan of reorganization under section 524(g) of the Bankruptcy Code and utilize this specialized provision to establish a trust that will address all current and future asbestos-related claims Following the Petition Date, the activities of Paddock became subject to review and oversight by the bankruptcy court. As a result, the Company no longer has exclusive control over Paddock’s activities during the Chapter 11 proceedings. Therefore, Paddock was deconsolidated as of the Petition Date, and its assets and liabilities, which primarily included $47 million of cash, the legacy asbestos-related liabilities, as well as certain other assets and liabilities as of the Petition Date, were derecognized from the Company’s consolidated financial statements on a prospective basis. Simultaneously, the Company recognized a liability related to the Paddock support agreement, as described above, of $471 million as required under applicable accounting standards. The deconsolidation and Paddock support agreement resulted in a loss of approximately $14 million, which was reflected as a charge in the Company’s first quarter 2020 operating results. Additionally, the deconsolidation resulted in an investing outflow of $47 million in the Company’s first quarter 2020 consolidated cash flows. On February 23, 2021, Paddock and O-I Glass commenced a court-approved mediation process regarding the terms of a potential consensual plan of reorganization pursuant to section 524(g) of the Bankruptcy Code with the Official Committee of Asbestos Personal Injury Claimants (the “ACC” or “Asbestos Claimants’ Committee”) appointed in the Paddock Chapter 11 case as the representative of current Paddock asbestos claimants, and the Legal Representative of Future Asbestos Claimants (the “FCR” or “Future Claimants’ Representative”) appointed in the Paddock Chapter 11 case as the representative of future Paddock asbestos claimants. On April 26, 2021, the Company announced that Paddock, the ACC and the FCR reached an agreement in principle, supported by O-I Glass, by accepting a proposal from the mediators setting forth total consideration to fund a trust created under section 524(g) of the Bankruptcy Code upon the effective date of a consensual plan of reorganization for Paddock. This agreement in principle, which is subject to definitive documentation and satisfaction of certain conditions, will resolve the potential liability of Paddock and the Company Protected Parties for pending and future personal injury claims related to exposure to asbestos-containing products that were allegedly manufactured, distributed, used and/or sold by Owens-Illinois, Inc. Under the Chapter 11 plan that will implement the agreement in principle, an asbestos settlement trust (the “Paddock Trust”) created pursuant to the provisions of section 524(g) of the U.S. Bankruptcy Code will be established and, on the effective date of the Chapter 11 plan, will be funded with $610 million in total consideration (“Settlement Consideration”). In exchange for the Settlement Consideration, each of the Company Protected Parties is expected to receive the benefit of a release from Paddock, and Paddock and the Company Protected Parties will receive the benefit of an injunction under Section 524(g) of the Bankruptcy Code channeling Asbestos Claims to the Paddock Trust and permanently enjoining the assertion of Asbestos Claims against Paddock and the Company Protected Parties. The agreement in principle is subject to, among other things, the negotiation and filing of a Chapter 11 plan of reorganization for Paddock incorporating the terms of such agreement (the “Plan”), acceptance of the Plan by at least 75% of Paddock’s current asbestos claimants voting on such Plan, and confirmation of the Plan by the Bankruptcy Court and approval of the injunction in favor of Paddock and the Company Protected Parties by the United States District Court for the District of Delaware (“District Court”). On the effective date of the Plan, the Settlement Consideration will be provided and Asbestos Claims against Paddock and the Company Protected Parties will be permanently enjoined. In connection with the agreement in principle, the Company has recorded a charge of $154 million related to its potential liability under the Paddock support agreement as a recognizable subsequent event in the Company’s condensed consolidated results of operations for the quarter ended March 31, 2021, primarily related to an increase to Paddock’s asbestos reserve estimate in consideration for the channeling injunction to be included in the Plan protecting Company Protected Parties from Asbestos Claims, as well as certain other adjustments to Paddock’s assets and liabilities, including estimated professional fees and expenses to be incurred in confirming and implementing the Plan. This charge was recorded to Other income (expense), net on the Condensed Consolidated Results of Operations. Several risks and uncertainties remain related to Paddock’s Chapter 11 case that could have a material adverse effect on the Company’s business, consolidated financial condition, results of operations and cash flows, including the total costs of the Chapter 11 proceeding, and the length of time necessary to confirm a Plan, and the possibility that Paddock will be unsuccessful in confirming such Plan or that such Plan does not ultimately become effective. The Paddock support agreement liability of $625 million recorded on the Company’s September 30, 2021 Condensed Consolidated Balance Sheet as required under applicable accounting standards is the Company’s best estimate based on the facts and circumstances that exist at the Form 10-Q filing date. These risk factors are discussed further in Part II, Item 1A–“Risk Factors.” Prior to the Petition Date, the Company knew of approximately 850 asbestos lawsuits pending. This figure does not include an estimate of potential Administrative Claims that could have been presented under a claims-handling agreement due to the uncertainties around presentation timing, quantities, or qualification rates. The Company historically considered Administrative Claims to be filed and disposed of when they were accepted for payment. The lack of uniform rules in lawsuit pleading practice, technical pleading requirements in some jurisdictions, local rules, and other factors caused considerable variation in the specific amounts of monetary damages asserted in lawsuits brought prior to the Petition Date. In the Company’s experience, the monetary relief alleged in a lawsuit bore little relationship to an Asbestos Claim’s merits or its disposition value. Rather, several variables, including, but not limited to, the type and severity of the asbestos disease, medical history, and exposure to other disease-causing agents; the product identification evidence against the Company and other co-defendants; the defenses available to the Company and other co-defendants; the specific jurisdiction in which the claim was made; the applicable law; and the law firm representing the claimant, affected the value. The Company was also a defendant in other Asbestos Claims involving maritime workers, medical monitoring, co-defendants’ third-party actions, and property damage allegations. Based upon its experience, the Company assessed that these categories of Asbestos Claims would not involve any material liability. Therefore, they were not included in the description of pending or disposed matters. From receipt of its first Asbestos Claim to the Petition Date, the Company in the aggregate disposed of approximately 401,200 Asbestos Claims at an average indemnity payment of approximately $10,200 per claim. The Company’s asbestos indemnity payments varied on a per-claim basis. Asbestos-related cash payments for 2019 were $151 million and the Company’s cash payments per claim disposed (inclusive of legal costs) were approximately $129,000 for the year ended December 31, 2019. Prior to the Petition Date, the Company’s objective was historically to achieve, where possible, resolution of Asbestos Claims pursuant to claims-handling agreements. Failure of claimants to meet certain medical and product exposure criteria in claims-handling agreements generally reduced the number of claims that would otherwise have been received by the Company in the tort system. In addition, changes in jurisdictional dynamics, legislative acts, asbestos docket management and procedures, the substantive law, the co-defendant pool, and other external factors affected lawsuit volume, claim volume, qualification rates, claim values, and related matters. Collectively, these variables generally had the effect of increasing the Company’s per-claim average indemnity payment over time. Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total of approximately $5.0 billion through just prior to the Petition Date, before insurance recoveries, for its asbestos-related liability. The Company’s estimates of its liability were significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that filed for bankruptcy, changes in mortality rates, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the significant expansion of the types of defendants sued in this litigation, and changes in the extent to which such defendants participated in the resolution of cases in which the Company was also a defendant. Prior to the Petition Date, the Company continually monitored trends that could affect its ultimate liability and analyzed the developments and variables likely to affect the resolution of Asbestos Claims. The material components of the Company’s total accrued liability were determined by the Company in connection with its annual comprehensive legal review and consisted of the following estimates, to the extent it was probable that such liabilities had been incurred and could be reasonably estimated: (i) the liability for Asbestos Claims already asserted against the Company; (ii) the liability for Asbestos Claims not yet asserted against the Company; and (iii) the legal defense costs estimated to be incurred in connection with the Asbestos Claims already asserted and those Asbestos Claims the Company believed would be asserted. Through December 31, 2019, the Company historically conducted an annual comprehensive legal review of its asbestos-related liabilities and costs in connection with finalizing and reporting its annual consolidated results of operations, unless significant changes in trends or new developments warranted an earlier review. As part of its annual comprehensive legal review, the Company provided historical Asbestos Claims data to a third party with expertise in determining the impact of disease incidence and mortality on future filing trends to develop information to assist the Company in estimating the total number of future Asbestos Claims likely to be asserted against the Company. The Company used this estimate, along with an estimation of disposition costs and related legal costs, as inputs to develop its best estimate of its total probable liability. If the results of the annual comprehensive legal review indicated that the existing amount of the accrued liability was lower (higher) than its reasonably estimable asbestos-related costs, then the Company recorded an appropriate charge (credit) to the Company’s results of operations to increase (decrease) the accrued liability. The significant assumptions underlying the material components of the Company’s accrual historically were: a) settlements would continue to be limited almost exclusively to claimants who were exposed to the Company’s asbestos containing insulation prior to its exit from that business in 1958; b) Asbestos Claims would continue to be resolved primarily under the Company’s administrative claims-handling agreements or on terms comparable to those set forth in those agreements; c) the incidence of serious asbestos-related disease cases and claiming patterns against the Company for such cases would not change materially, including claiming pattern changes driven by changes in the law, procedure, or expansion of judicial resources in jurisdictions where the Company settled Asbestos Claims; d) the Company would be substantially able to defend itself successfully at trial and on appeal; e) the number and timing of additional co-defendant bankruptcies would not change significantly the assets available to participate in the resolution of cases in which the Company is a defendant; and f) co-defendants with substantial resources and assets would continue to participate significantly in the resolution of future Asbestos Claims. For the year ended December 31, 2019, the Company concluded that an accrual in the amount of $486 million was required under applicable accounting standards. This amount was not discounted for the time value of money. The Company’s comprehensive legal review resulted in a charge of $ million for the year ended December 31, 2019. As previously disclosed, the Company anticipated that adjustments to its asbestos-related accruals were possible given the inherent uncertainties involved in asbestos litigation. In the fourth quarter of 2019, this charge was primarily due to an increase in the estimated average disposition cost per claim (including related legal costs), driven primarily by a changing litigation environment more favorable to plaintiffs, and a decrease in the estimated number of claims likely to be asserted against the Company in the future that was less than the decrease expected by the Company. Other Matters In February 2021, severe weather conditions swept across the southern United States, curtailing access to natural gas and electricity for several of the Company’s facilities. While the situation was most acute in Texas, access to natural gas in Mexico was also significantly impacted as Texas supplies natural gas to the country. The Company was notified by energy providers in both the United States and Mexico that it may be assessed surcharges for usage or excess usage of electricity and natural gas during that period. Although most of these surcharges had not yet been formally assessed as of the first quarter of 2021, the Company believed that these costs were probable and reasonably estimable and therefore had accrued approximately $20 million as of March 31, 2021, which was based on the best information available at that time. Subsequent to March 31, 2021, the Company has paid or agreed to pay approximately $3 million of the energy surcharges to certain providers. The Company was notified by certain providers that approximately $6 million of the potential surcharges would not be assessed and therefore the related accruals were reversed to earnings. At September 30, 2021, the Company had approximately $11 million accrued for this matter. In the second quarter of 2021, the Company recorded a $69 million gain based on a favorable court ruling in Brazil, which will allow the Company to recover indirect taxes paid in previous years. This gain was recorded to Other income (expense), net on the Condensed Consolidated Results of Operations, as well as $28 million of income tax expense that was recognized as a discrete item in the second quarter of 2021. Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events. |
Share Owners' Equity
Share Owners' Equity | 9 Months Ended |
Sep. 30, 2021 | |
Share Owners' Equity | |
Share Owners' Equity | 11. Share Owners’ Equity The activity in share owners’ equity for the three months ended September 30, 2021 and 2020 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on July 1, 2021 $ 2 $ 3,113 (709) $ 173 $ (2,180) $ 103 $ 502 Reissuance of common stock (0.2 million shares) (1) 4 3 Shares repurchased (0.6 million shares) (10) (10) Stock compensation (0.0 million shares) 3 3 Net earnings 85 6 91 Other comprehensive income (loss) (18) (1) (19) Balance on September 30, 2021 $ 2 $ 3,105 $ (705) $ 258 $ (2,198) $ 108 $ 570 Share Owners’ Equity of the Company Accumulated Capital in Retained Other Non- Total Share Common Excess of Treasury Earnings Comprehensive controlling Owners' Stock Par Value Stock (Loss) Loss Interests Equity Balance on July 1, 2020 $ 2 $ 3,128 $ (724) $ (147) $ (2,308) $ 91 $ 42 Reissuance of common stock (0.2 million shares) (3) 5 2 Stock compensation (0.1 million shares) 3 3 Net earnings 328 7 335 Other comprehensive income (loss) (117) (117) Balance on September 30, 2020 $ 2 $ 3,128 $ (719) $ 181 $ (2,425) $ 98 $ 265 The activity in share owners’ equity for the nine months ended September 30, 2021 and 2020 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2021 $ 2 $ 3,129 $ (714) $ 152 $ (2,272) $ 104 $ 401 Issuance of common stock (0.05 million shares) 1 1 Reissuance of common stock (0.3 million shares) (4) 11 7 Shares repurchased (1.0 million shares) (30) (30) Stock compensation (0.6 million shares) 11 11 Net earnings 106 17 123 Other comprehensive income (loss) 74 (14) 60 Other (2) (2) 1 (3) Balance on September 30, 2021 $ 2 $ 3,105 $ (705) $ 258 $ (2,198) $ 108 $ 570 Share Owners’ Equity of the Company Accumulated Capital in Retained Other Non- Total Share Common Excess of Treasury Earnings Comprehensive controlling Owners' Stock Par Value Stock (Loss) Loss Interests Equity Balance on January 1, 2020 $ 2 $ 3,130 $ (733) $ (89) $ (1,843) $ 97 $ 564 Reissuance of common stock (0.7 million shares) (10) 17 7 Stock compensation (0.9 million shares) 8 8 Net earnings 278 11 289 Other comprehensive income (loss) (582) (10) (592) Dividends declared (8) (8) Other (3) (3) Balance on September 30, 2020 $ 2 $ 3,128 $ (719) $ 181 $ (2,425) $ 98 $ 265 During the three months ended September 30, 2021, the Company purchased 619,666 shares of its common stock for approximately $10 million. The stock purchases were to the Company’s directors, officers, and employees. Approximately $120 million remained available for purchases under this program as of September 30, 2021. The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows: Shares Outstanding (in thousands) September 30, December 31, September 30, 2021 2020 2020 Shares of common stock issued (including treasury shares) 188,426 189,305 189,302 Treasury shares 31,599 31,911 32,136 |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 9 Months Ended |
Sep. 30, 2021 | |
Accumulated Other Comprehensive Loss | |
Accumulated Other Comprehensive Loss | 12. Accumulated Other Comprehensive Loss The activity in accumulated other comprehensive loss for the three months ended September 30, 2021 and 2020 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2021 $ (1,187) $ (47) $ (946) $ (2,180) Change before reclassifications (109) 37 47 (25) Amounts reclassified from accumulated other comprehensive loss (25) (a) 24 (b) (1) Translation effect 7 7 Tax effect 1 1 Other comprehensive income (loss) attributable to the Company (109) 13 78 (18) Balance on September 30, 2021 $ (1,296) $ (34) $ (868) $ (2,198) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2020 $ (1,321) $ (21) $ (966) $ (2,308) Change before reclassifications 1 (88) 30 (57) Amounts reclassified from accumulated other comprehensive income (loss) 78 (a) 17 (b) 95 Amounts reclassified from accumulated other comprehensive income (loss) related to ANZ sale (149) 1 4 (144) Translation effect (1) (9) (10) Tax effect (1) (1) Other comprehensive income (loss) attributable to the Company (148) (11) 42 (117) Balance on September 30, 2020 $ (1,469) $ (32) $ (924) $ (2,425) (a) Amount is recorded to Other income (expense), net and interest expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost. The activity in accumulated other comprehensive loss for the nine months ended September 30, 2021 and 2020 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2021 $ (1,229) $ (60) $ (983) $ (2,272) Change before reclassifications (67) 83 45 61 Amounts reclassified from accumulated other comprehensive income (loss) (59) (a) 63 (b) 4 Translation effect 1 7 8 Tax effect 1 1 Other comprehensive income (loss) attributable to the Company (67) 26 115 74 Balance on September 30, 2021 $ (1,296) $ (34) $ (868) $ (2,198) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on January 1, 2020 $ (813) $ (14) $ (1,016) $ (1,843) Change before reclassifications (507) (81) 27 (561) Amounts reclassified from accumulated other comprehensive income (loss) 67 (a) 59 (b) 126 Amounts reclassified from accumulated other comprehensive income (loss) related to ANZ sale (149) 1 4 (144) Translation effect (3) 4 1 Tax effect (2) (2) (4) Other comprehensive income (loss) attributable to the Company (656) (18) 92 (582) Balance on September 30, 2020 $ (1,469) $ (32) $ (924) $ (2,425) (a) Amount is recorded to Other income (expense), net and interest expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost. |
Other Income (Expense), Net
Other Income (Expense), Net | 9 Months Ended |
Sep. 30, 2021 | |
Other Income (Expense), Net | |
Other Income (Expense), Net | 13. Other Income (Expense), Net Other income (expense), net for the three and nine months ended September 30, 2021 and 2020 included the following: Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Gain on sale of ANZ businesses $ — $ 280 $ — $ 280 Restructuring, asset impairment and other charges (12) (9) (21) (80) Brazil indirect tax credit 69 Pension settlement charges (5) (5) (8) Charge related to Paddock support agreement liability (see Note 10) (154) Intangible amortization expense (9) (8) (26) (23) Strategic transaction costs (3) (7) Foreign currency exchange loss (1) (1) (3) (3) Royalty income 6 2 17 8 Charge for deconsolidation of Paddock (see Note 10) (14) Other (11) (6) Other income (expense), net $ (21) $ 250 $ (123) $ 147 |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Sep. 30, 2021 | |
Earnings Per Share | |
Earnings Per Share | 14. Earnings Per Share The following tables set forth the computation of basic and diluted earnings per share: Three months ended September 30, 2021 2020 Numerator: Net earnings attributable to the Company $ 85 $ 328 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 156,825 157,073 Effect of dilutive securities: Stock options and other 3,686 2,226 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 160,511 159,299 Basic earnings per share: Earnings from continuing operations attributable to the Company $ 0.49 $ 2.09 Gain from discontinued operations 0.05 Net earnings $ 0.54 $ 2.09 Diluted earnings per share: Earnings from continuing operations attributable to the Company $ 0.48 $ 2.06 Gain from discontinued operations 0.05 Net earnings $ 0.53 $ 2.06 The diluted earnings per share computation for the three months ended September 30, 2021 and 2020 excludes 958,014 and 1,564,207 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes options to purchase, unvested restricted stock units and performance vested restricted share units. Options to purchase shares were excluded because the exercise prices of the options were greater than the average market price of the common shares. Nine months ended September 30, 2021 2020 Numerator: Net earnings attributable to the Company $ 106 $ 278 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 157,430 156,650 Effect of dilutive securities: Stock options and other 3,043 1,788 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 160,473 158,438 Basic earnings per share: Earnings from continuing operations attributable to the Company $ 0.62 $ 1.77 Gain from discontinued operations 0.05 Net earnings $ 0.67 $ 1.77 Diluted earnings per share: Earnings from continuing operations attributable to the Company $ 0.61 $ 1.76 Gain from discontinued operations 0.05 Net earnings $ 0.66 $ 1.76 The diluted earnings per share computation for the nine months ended September 30, 2021 and 2020 excludes 1,206,870 and 2,616,538 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes options to purchase, unvested restricted stock units and performance vested restricted share units. Options to purchase shares were excluded because the exercise prices of the options were greater than the average market price of the common shares. |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 9 Months Ended |
Sep. 30, 2021 | |
Supplemental Cash Flow Information | |
Supplemental Cash Flow Information | 15. Supplemental Cash Flow Information Income taxes paid in cash were as follows: Nine months ended September 30, 2021 2020 U.S. $ 6 $ 1 Non-U.S. 58 53 Total income taxes paid in cash $ 64 $ 54 Interest paid, including note repurchase premiums, in cash for the nine months ended September 30, 2021 and 2020 was $144 million and $196 million, respectively. Cash interest for the nine months ended September 30, 2020 included $41 million for note repurchase premiums. The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. At September 30, 2021, December 31, 2020 and September 30, 2020, the amount of receivables sold by the Company was $416 million, $436 million and $426 million, respectively. These amounts included $189 million, $176 million and $188 million at September 30, 2021, December 31, 2020, and September 30, 2020, respectively, for trade receivable amounts factored under supply chain financing programs linked to commercial arrangements with key customers. million, respectively. |
New Accounting Pronouncement
New Accounting Pronouncement | 9 Months Ended |
Sep. 30, 2021 | |
New Accounting Pronouncement | |
New Accounting Pronouncement | 16. New Accounting Pronouncement Effects of Reference Rate Reform on Financial Reporting reference rate that is expected to be discontinued as a result of reference rate reform. To date, no significant contracts that reference LIBOR have been modified by the Company. The Company adopted ASU No. 2020-04 effective July 1, 2020. The adoption of this ASU had no impact on |
COVID-19 Impacts
COVID-19 Impacts | 9 Months Ended |
Sep. 30, 2021 | |
COVID-19 Impacts | |
COVID-19 Impacts | 17. COVID-19 Impacts On March 11, 2020, the World Health Organization characterized COVID-19 as a global pandemic and recommended containment and mitigation measures. The Company is actively monitoring the impact of the COVID-19 pandemic, which negatively impacted its business in 2020 and, to a lesser extent, the first nine months of 2021 and may negatively impact its business and results of operations in the future. The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates particularly as it relates to estimates reliant on forecasts and other assumptions reasonably available to the Company and the uncertain future impacts of the COVID-19 pandemic and related economic disruptions. The extent to which the COVID-19 pandemic and related economic disruptions impact the Company’s business and financial results will depend on future developments including, but not limited to, the continued spread, duration and severity of the COVID-19 pandemic; the occurrence, spread, duration and severity of any subsequent wave or waves of outbreaks after the initial outbreak has subsided; the actions taken by the U.S. and foreign governments to contain the COVID-19 pandemic, address its impact or respond to the reduction in global and local economic activity; the occurrence, duration and severity of a global, regional or national recession, depression or other sustained adverse market event; the impact of the developments described above on its customers and suppliers; and how quickly and to what extent normal economic and operating conditions can resume. The accounting matters assessed included, but were not limited to: • allowance for doubtful accounts and credit losses; • carrying value of inventory; and • the carrying value of goodwill and other long-lived assets. There was not a material impact to the above estimates in the Company’s Condensed Consolidated Financial Statements for the three- and nine-month periods ended September 30, 2021 or September 30, 2020. The Company’s future assessment of the magnitude and duration of the COVID-19 pandemic, as well as other factors, could result in material changes to the estimates and material impacts to the Company’s Condensed Consolidated Financial Statements in future reporting periods. |
Divestitures
Divestitures | 9 Months Ended |
Sep. 30, 2021 | |
Divestitures | |
Divestitures | 18. Divestitures On July 31, 2020, the Company completed the sale of its ANZ businesses to Visy, an unaffiliated company. Gross proceeds approximated AUD $947 million (including a related sale-leaseback agreement which approximated AUD $214 million), or approximately USD $677 million. Approximately 95% of those proceeds were received at the time of closing, and the remaining balance of approximately $58 million was received in the first quarter of 2021. In 2020, the Company recognized a net gain (including costs directly attributable to the sale of ANZ and subject to post-closing adjustments) on the divestiture of approximately $275 million, which was reported on the Other income (expense), net line in the Consolidated Results of Operations. In addition, at closing, certain subsidiaries of the Company entered into certain ancillary agreements with Visy and the ANZ businesses in respect of the provision of certain transitional and technical services to the ANZ businesses. In January 2021, the Company completed the sale of its plant in Argentina. Gross proceeds are approximately $10 million, and the gain on the sale was not material. |
Subsequent Event
Subsequent Event | 9 Months Ended |
Sep. 30, 2021 | |
Subsequent Event | |
Subsequent Event | 19. Subsequent Event On October 25, 2021, the Company announced that it had entered into a binding commitment to sell its Le Parfait brand and business to a subsidiary of Berlin Packaging L.L.C., a global packaging supplier. Le Parfait is a French jar brand sold in more than 20 countries. The proposed sale is expected to generate gross proceeds of approximately €72 million, which will be redeployed to help fund expansion initiatives, such as the Company’s MAGMA innovation. O-I expects to close around year end 2021, subject to the works council consultation and other customary closing conditions. The proposed transaction between O-I and Berlin Packaging L.L.C. also includes a long-term supply arrangement to manufacture Le Parfait jars from O-I plants in France and Spain. |
Segment Information (Tables)
Segment Information (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Segment Information | |
Net sales for the Company's reportable segments | Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Net sales: Americas $ 925 $ 887 $ 2,652 $ 2,442 Europe 655 644 2,039 1,775 Asia Pacific 52 281 Reportable segment totals 1,580 1,583 4,691 4,498 Other 29 33 79 97 Net sales $ 1,609 $ 1,616 $ 4,770 $ 4,595 |
Segment operating profit (loss) for the Company's reportable segments | Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Segment operating profit: Americas $ 133 $ 113 $ 357 $ 268 Europe 110 88 293 191 Asia Pacific 3 19 Reportable segment totals 243 204 650 478 Items excluded from segment operating profit: Retained corporate costs and other (49) (35) (126) (98) Gain on sale of ANZ businesses 280 280 Brazil indirect tax credit 69 Restructuring, asset impairment and other charges (12) (9) (21) (80) Charge related to Paddock support agreement liability (154) Charge for deconsolidation of Paddock (14) Pension settlement charges (5) (5) (8) Strategic transaction costs (3) (7) Interest expense, net (50) (61) (153) (212) Earnings from continuing operations before income taxes $ 127 $ 376 $ 260 $ 339 |
Total assets for the Company's reportable segments | September 30, December 31, September 30, 2021 2020 2020 Total assets: Americas $ 4,925 $ 4,927 $ 4,663 Europe 3,457 3,507 3,307 Reportable segment totals 8,382 8,434 7,970 Other 384 448 654 Consolidated totals $ 8,766 $ 8,882 $ 8,624 |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Revenue | |
Schedule of disaggregation of revenue by customer end use | Three months ended September 30, 2021 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 561 $ 467 $ — $ 1,028 Food and other 215 124 339 Non-alcoholic beverages 149 64 213 Reportable segment totals $ 925 $ 655 $ — $ 1,580 Other 29 Net sales $ 1,609 Three months ended September 30, 2020 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 537 $ 452 $ 40 $ 1,029 Food and other 222 138 6 366 Non-alcoholic beverages 128 54 6 188 Reportable segment totals $ 887 $ 644 $ 52 $ 1,583 Other 33 Net sales $ 1,616 Nine months ended September 30, 2021 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 1,610 $ 1,507 $ — $ 3,117 Food and other 627 366 993 Non-alcoholic beverages 415 166 581 Reportable segment totals $ 2,652 $ 2,039 $ — $ 4,691 Other 79 Net sales $ 4,770 Nine months ended September 30, 2020 Americas Europe Asia Pacific Total Alcoholic beverages (beer, wine, spirits) $ 1,471 $ 1,258 $ 217 $ 2,946 Food and other 609 360 38 1,007 Non-alcoholic beverages 362 157 26 545 Reportable segment totals $ 2,442 $ 1,775 $ 281 $ 4,498 Other 97 Net sales $ 4,595 |
Inventories (Tables)
Inventories (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Inventories | |
Major classes of inventory | September 30, December 31, September 30, 2021 2020 2020 Finished goods $ 651 $ 675 $ 625 Raw materials 120 129 121 Operating supplies 37 37 36 $ 808 $ 841 $ 782 |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Derivative Instruments | |
Balance Sheet Classification of derivative instruments | Fair Value of Fair Value of Hedge Assets Hedge Liabilities September 30, December 31, September 30, September 30, December 31, September 30, 2021 2020 2020 2021 2020 2020 Derivatives designated as hedging instruments: Interest rate swaps - fair value hedges (a) $ 9 $ 17 $ 16 $ 1 $ — $ — Cash flow hedges of foreign exchange risk (b) 9 6 9 54 115 67 Net investment hedges (c) 2 1 2 28 52 27 Total derivatives accounted for as hedges $ 20 $ 24 $ 27 $ 83 $ 167 $ 94 Derivatives not designated as hedges: Foreign exchange derivative contracts (d) 1 1 3 4 3 6 Total derivatives $ 21 $ 25 $ 30 $ 87 $ 170 $ 100 Current $ 15 $ 13 $ 16 $ 4 $ 15 $ 13 Noncurrent 6 12 14 83 155 87 Total derivatives $ 21 $ 25 $ 30 $ 87 $ 170 $ 100 (a) The notional amounts of the interest rate swaps designated as fair value hedges were €725 million at September 30, 2021, December 31, 2020 and September 30, 2020. The maximum maturity dates were in 2024 for all three periods. (b) The notional amounts of the cash flow hedges of foreign exchange risk were $878 million at September 30, 2021, $978 million at December 31, 2020 and $1.1 billion at September 30, 2020. The maximum maturity dates were in 2023 for all three periods. (c) The notional amounts of the net investment hedges were €311 million at September 30, 2021, €311 million at December 31, 2020 and €311 million at September 30, 2020. The maximum maturity dates were in 2027 for September 30, 2021 and December 31, 2020 and in 2020 for September 30, 2020. (d) The notional amounts of the foreign exchange derivative contracts were $291 million, $247 million and $247 million at September 30, 2021, December 31, 2020 and September 30, 2020, respectively. The maximum maturity dates were in 2021 for all three periods. Gain (Loss) Recognized in OCI (Effective Portion) Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) Three months ended September 30, Three months ended September 30, Derivatives designated as hedging instruments: 2021 2020 2021 2020 Cash Flow Hedges Cash flow hedges of foreign exchange risk (a) $ 24 $ (61) $ 24 $ (80) Cash flow hedges of interest rate risk (b) Net Investment Hedges Net Investment Hedges (b) 13 (26) 1 1 $ 37 $ (87) $ 25 $ (79) Gain (Loss) Recognized in OCI (Effective Portion) Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) Nine months ended September 30, Nine months ended September 30, Derivatives designated as hedging instruments: 2021 2020 2021 2020 Cash Flow Hedges Cash flow hedges of foreign exchange risk (a) $ 56 $ (51) $ 57 $ (71) Cash flow hedges of interest rate risk (b) (1) Net Investment Hedges Net Investment Hedges (b) 27 (29) 2 4 $ 83 $ (80) $ 59 $ (68) Amount of Gain (Loss) Recognized in Other income (expense), net Amount of Gain (Loss) Recognized in Other income (expense), net Three months ended September 30, Nine months ended September 30, Derivatives not designated as hedges: 2021 2020 2021 2020 Foreign exchange derivative contracts $ 2 $ 3 $ 9 $ 13 (1) Gains and losses reclassified from accumulated OCI and recognized in income are recorded to (a) other income (expense), net or (b) interest expense, net. |
Effects of derivative instruments on the results of operations | |
Restructuring (Tables)
Restructuring (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Restructuring Accruals | |
Selected information related to the restructuring accruals | Selected information related to the restructuring accruals for the three months ended September 30, 2021 and 2020 is as follows: Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at July 1, 2021 $ 32 $ — $ 12 $ 44 Charges 1 11 12 Write-down of assets to net realizable value (1) (1) Net cash paid, principally severance and related benefits (4) (1) (5) Other, including foreign exchange translation — Balance at September 30, 2021 $ 28 $ — $ 22 $ 50 Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at July 1, 2020 $ 30 $ — $ 17 $ 47 Charges 2 3 5 Write-down of assets to net realizable value (3) (3) Net cash paid, principally severance and related benefits (10) (10) Other, including foreign exchange translation (4) (4) Balance at September 30, 2020 $ 22 $ — $ 13 $ 35 Selected information related to the restructuring accruals for the nine months ended September 30, 2021 and 2020 is as follows: Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2021 $ 38 $ — $ 7 $ 45 Charges 2 1 17 20 Write-down of assets to net realizable value (1) (1) Net cash paid, principally severance and related benefits (11) (3) (14) Other, including foreign exchange translation (1) 1 — Balance at September 30, 2021 $ 28 $ — $ 22 $ 50 Employee Asset Other Total Costs Impairment Exit Costs Restructuring Balance at January 1, 2020 $ 32 $ $ 13 $ 45 Charges 23 43 6 72 Write-down of assets to net realizable value (43) (43) Net cash paid, principally severance and related benefits (31) (1) (32) Other, including foreign exchange translation (2) (5) (7) Balance at September 30, 2020 $ 22 $ — $ 13 $ 35 |
Pension Benefit Plans (Tables)
Pension Benefit Plans (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Pension Benefit Plans | |
Defined Benefit Plans and Other Postretirement Benefit Plans | |
Components of net periodic pension cost | U.S. Non-U.S. 2021 2020 2021 2020 Service cost $ 3 $ 3 $ 3 $ 3 Interest cost 10 12 5 6 Expected asset return (21) (19) (11) (12) Amortization of actuarial loss 16 14 3 3 Net periodic pension cost $ 8 $ 10 $ — $ — U.S. Non-U.S. 2021 2020 2021 2020 Service cost $ 9 $ 9 $ 9 $ 10 Interest cost 30 37 15 19 Expected asset return (63) (60) (34) (36) Amortization of actuarial loss 48 42 10 9 Net periodic pension cost $ 24 $ 28 $ — $ 2 |
Debt (Tables)
Debt (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Debt | |
Long-term Debt | September 30, December 31, September 30, 2021 2020 2020 Secured Credit Agreement: Revolving Credit Facility: Revolving Loans $ — $ — $ 195 Term Loans: Term Loan A 1,068 1,067 1,157 Other secured debt 99 109 Senior Notes: 4.00%, due 2023 308 307 307 5.875%, due 2023 694 692 691 3.125%, due 2024 (€725 million) 854 914 873 6.375%, due 2025 297 296 296 5.375%, due 2025 298 298 298 2.875%, due 2025 (€500 million) 574 607 579 6.625%, due 2027 693 692 691 Finance leases 99 108 94 Other 5 7 6 Total long-term debt 4,890 5,087 5,296 Less amounts due within one year 37 142 133 Long-term debt $ 4,853 $ 4,945 $ 5,163 |
Fair values of the Company's significant fixed rate debt obligations | Principal Indicated Market Amount Price Per $ Fair Value Senior Notes: 5.875%, due 2023 $ 700 $ 106.00 $ 742 4.00%, due 2023 310 102.57 318 3.125%, due 2024 (€725 million) 841 103.53 871 6.375%, due 2025 300 110.86 333 5.375%, due 2025 300 107.11 321 2.875%, due 2025 (€500 million) 580 101.56 589 6.625%, due 2027 700 107.40 752 |
Share Owners' Equity (Tables)
Share Owners' Equity (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Share Owners' Equity | |
Activity in share owner's equity | The activity in share owners’ equity for the three months ended September 30, 2021 and 2020 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on July 1, 2021 $ 2 $ 3,113 (709) $ 173 $ (2,180) $ 103 $ 502 Reissuance of common stock (0.2 million shares) (1) 4 3 Shares repurchased (0.6 million shares) (10) (10) Stock compensation (0.0 million shares) 3 3 Net earnings 85 6 91 Other comprehensive income (loss) (18) (1) (19) Balance on September 30, 2021 $ 2 $ 3,105 $ (705) $ 258 $ (2,198) $ 108 $ 570 Share Owners’ Equity of the Company Accumulated Capital in Retained Other Non- Total Share Common Excess of Treasury Earnings Comprehensive controlling Owners' Stock Par Value Stock (Loss) Loss Interests Equity Balance on July 1, 2020 $ 2 $ 3,128 $ (724) $ (147) $ (2,308) $ 91 $ 42 Reissuance of common stock (0.2 million shares) (3) 5 2 Stock compensation (0.1 million shares) 3 3 Net earnings 328 7 335 Other comprehensive income (loss) (117) (117) Balance on September 30, 2020 $ 2 $ 3,128 $ (719) $ 181 $ (2,425) $ 98 $ 265 The activity in share owners’ equity for the nine months ended September 30, 2021 and 2020 is as follows: Share Owners’ Equity of the Company Accumulated Capital in Other Non- Total Share Common Excess of Treasury Retained Comprehensive controlling Owners' Stock Par Value Stock Earnings Loss Interests Equity Balance on January 1, 2021 $ 2 $ 3,129 $ (714) $ 152 $ (2,272) $ 104 $ 401 Issuance of common stock (0.05 million shares) 1 1 Reissuance of common stock (0.3 million shares) (4) 11 7 Shares repurchased (1.0 million shares) (30) (30) Stock compensation (0.6 million shares) 11 11 Net earnings 106 17 123 Other comprehensive income (loss) 74 (14) 60 Other (2) (2) 1 (3) Balance on September 30, 2021 $ 2 $ 3,105 $ (705) $ 258 $ (2,198) $ 108 $ 570 Share Owners’ Equity of the Company Accumulated Capital in Retained Other Non- Total Share Common Excess of Treasury Earnings Comprehensive controlling Owners' Stock Par Value Stock (Loss) Loss Interests Equity Balance on January 1, 2020 $ 2 $ 3,130 $ (733) $ (89) $ (1,843) $ 97 $ 564 Reissuance of common stock (0.7 million shares) (10) 17 7 Stock compensation (0.9 million shares) 8 8 Net earnings 278 11 289 Other comprehensive income (loss) (582) (10) (592) Dividends declared (8) (8) Other (3) (3) Balance on September 30, 2020 $ 2 $ 3,128 $ (719) $ 181 $ (2,425) $ 98 $ 265 |
Schedule of shares outstanding | Shares Outstanding (in thousands) September 30, December 31, September 30, 2021 2020 2020 Shares of common stock issued (including treasury shares) 188,426 189,305 189,302 Treasury shares 31,599 31,911 32,136 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Loss (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Accumulated Other Comprehensive Loss | |
Component of accumulated other comprehensive loss | The activity in accumulated other comprehensive loss for the three months ended September 30, 2021 and 2020 is as follows: Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2021 $ (1,187) $ (47) $ (946) $ (2,180) Change before reclassifications (109) 37 47 (25) Amounts reclassified from accumulated other comprehensive loss (25) (a) 24 (b) (1) Translation effect 7 7 Tax effect 1 1 Other comprehensive income (loss) attributable to the Company (109) 13 78 (18) Balance on September 30, 2021 $ (1,296) $ (34) $ (868) $ (2,198) Total Accumulated Net Effect of Change in Certain Other Exchange Rate Derivative Employee Comprehensive Fluctuations Instruments Benefit Plans Loss Balance on July 1, 2020 $ (1,321) $ (21) $ (966) $ (2,308) Change before reclassifications 1 (88) 30 (57) Amounts reclassified from accumulated other comprehensive income (loss) 78 (a) 17 (b) 95 Amounts reclassified from accumulated other comprehensive income (loss) related to ANZ sale (149) 1 4 (144) Translation effect (1) (9) (10) Tax effect (1) (1) Other comprehensive income (loss) attributable to the Company (148) (11) 42 (117) Balance on September 30, 2020 $ (1,469) $ (32) $ (924) $ (2,425) (a) Amount is recorded to Other income (expense), net and interest expense, net on the Condensed Consolidated Results of Operations (see Note 5 for additional information). (b) Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost. |
Other Income (Expense), Net (Ta
Other Income (Expense), Net (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Other Income (Expense), Net | |
Schedule of other income (expense), net | Three months ended September 30, Nine months ended September 30, 2021 2020 2021 2020 Gain on sale of ANZ businesses $ — $ 280 $ — $ 280 Restructuring, asset impairment and other charges (12) (9) (21) (80) Brazil indirect tax credit 69 Pension settlement charges (5) (5) (8) Charge related to Paddock support agreement liability (see Note 10) (154) Intangible amortization expense (9) (8) (26) (23) Strategic transaction costs (3) (7) Foreign currency exchange loss (1) (1) (3) (3) Royalty income 6 2 17 8 Charge for deconsolidation of Paddock (see Note 10) (14) Other (11) (6) Other income (expense), net $ (21) $ 250 $ (123) $ 147 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Earnings Per Share | |
Computation of basic and diluted earnings per share | Three months ended September 30, 2021 2020 Numerator: Net earnings attributable to the Company $ 85 $ 328 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 156,825 157,073 Effect of dilutive securities: Stock options and other 3,686 2,226 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 160,511 159,299 Basic earnings per share: Earnings from continuing operations attributable to the Company $ 0.49 $ 2.09 Gain from discontinued operations 0.05 Net earnings $ 0.54 $ 2.09 Diluted earnings per share: Earnings from continuing operations attributable to the Company $ 0.48 $ 2.06 Gain from discontinued operations 0.05 Net earnings $ 0.53 $ 2.06 Nine months ended September 30, 2021 2020 Numerator: Net earnings attributable to the Company $ 106 $ 278 Denominator (in thousands): Denominator for basic earnings per share-weighted average shares outstanding 157,430 156,650 Effect of dilutive securities: Stock options and other 3,043 1,788 Denominator for diluted earnings per share-adjusted weighted average shares outstanding 160,473 158,438 Basic earnings per share: Earnings from continuing operations attributable to the Company $ 0.62 $ 1.77 Gain from discontinued operations 0.05 Net earnings $ 0.67 $ 1.77 Diluted earnings per share: Earnings from continuing operations attributable to the Company $ 0.61 $ 1.76 Gain from discontinued operations 0.05 Net earnings $ 0.66 $ 1.76 |
Supplemental Cash Flow Inform_2
Supplemental Cash Flow Information (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Supplemental Cash Flow Information | |
Income taxes paid (received) in cash | Nine months ended September 30, 2021 2020 U.S. $ 6 $ 1 Non-U.S. 58 53 Total income taxes paid in cash $ 64 $ 54 |
Segment Information (Details)
Segment Information (Details) - segment | 9 Months Ended | 12 Months Ended |
Sep. 30, 2021 | Dec. 31, 2019 | |
Segment Reporting Information | ||
Number of reportable segments | 3 | |
Number of operating segments | 3 | |
Australia And New Zealand ("ANZ") business | ||
Segment Reporting Information | ||
Percentage of net sales of segment | 85.00% |
Segment Information - Reportabl
Segment Information - Reportable Segments (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||||
Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Net sales: | |||||||
Net sales | $ 1,609 | $ 1,616 | $ 4,770 | $ 4,595 | |||
Items excluded from segment operating profit: | |||||||
Retained corporate costs and other | (49) | (35) | (126) | (98) | |||
Gain on sale of ANZ businesses | 280 | 280 | |||||
Brazil indirect tax credit | $ 69 | 69 | |||||
Restructuring, asset impairment and other charges | (12) | (9) | (21) | (80) | |||
Charge related to Paddock support agreement liability | $ (154) | (154) | |||||
Charge for deconsolidation of Paddock | $ (14) | (14) | |||||
Pension settlement charges | (5) | (5) | (8) | ||||
Strategic transaction costs | (3) | (7) | |||||
Interest expense, net | (50) | (61) | (153) | (212) | |||
Earnings from continuing operations before income taxes | |||||||
Earnings from continuing operations before income taxes | 127 | 376 | 260 | 339 | |||
Reportable Segment Totals | |||||||
Net sales: | |||||||
Net sales | 1,580 | 1,583 | 4,691 | 4,498 | |||
Segment operating profit: | |||||||
Segment operating profit | 243 | 204 | 650 | 478 | |||
Americas | |||||||
Net sales: | |||||||
Net sales | 925 | 887 | 2,652 | 2,442 | |||
Segment operating profit: | |||||||
Segment operating profit | 133 | 113 | 357 | 268 | |||
Europe | |||||||
Net sales: | |||||||
Net sales | 655 | 644 | 2,039 | 1,775 | |||
Segment operating profit: | |||||||
Segment operating profit | 110 | 88 | 293 | 191 | |||
Asia Pacific | |||||||
Net sales: | |||||||
Net sales | 52 | 281 | |||||
Segment operating profit: | |||||||
Segment operating profit | 3 | 19 | |||||
Other | |||||||
Net sales: | |||||||
Net sales | $ 29 | $ 33 | $ 79 | $ 97 |
Segment Information - Total Ass
Segment Information - Total Assets (Details) - USD ($) $ in Millions | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
Assets | |||
Total assets: | $ 8,766 | $ 8,882 | $ 8,624 |
Reportable Segment Totals | |||
Assets | |||
Total assets: | 8,382 | 8,434 | 7,970 |
Americas | |||
Assets | |||
Total assets: | 4,925 | 4,927 | 4,663 |
Europe | |||
Assets | |||
Total assets: | 3,457 | 3,507 | 3,307 |
Other | |||
Assets | |||
Total assets: | $ 384 | $ 448 | $ 654 |
Revenue (Details)
Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Disaggregation of Revenue | ||||
Net sales | $ 1,609 | $ 1,616 | $ 4,770 | $ 4,595 |
Reportable Segment Totals | ||||
Disaggregation of Revenue | ||||
Net sales | 1,580 | 1,583 | 4,691 | 4,498 |
Americas | ||||
Disaggregation of Revenue | ||||
Net sales | 925 | 887 | 2,652 | 2,442 |
Europe | ||||
Disaggregation of Revenue | ||||
Net sales | 655 | 644 | 2,039 | 1,775 |
Asia Pacific | ||||
Disaggregation of Revenue | ||||
Net sales | 52 | 281 | ||
Other | ||||
Disaggregation of Revenue | ||||
Net sales | 29 | 33 | 79 | 97 |
Alcoholic beverages (beer, wine, spirits) | ||||
Disaggregation of Revenue | ||||
Net sales | 1,028 | 1,029 | 3,117 | 2,946 |
Alcoholic beverages (beer, wine, spirits) | Americas | ||||
Disaggregation of Revenue | ||||
Net sales | 561 | 537 | 1,610 | 1,471 |
Alcoholic beverages (beer, wine, spirits) | Europe | ||||
Disaggregation of Revenue | ||||
Net sales | 467 | 452 | 1,507 | 1,258 |
Alcoholic beverages (beer, wine, spirits) | Asia Pacific | ||||
Disaggregation of Revenue | ||||
Net sales | 40 | 217 | ||
Food and other | ||||
Disaggregation of Revenue | ||||
Net sales | 339 | 366 | 993 | 1,007 |
Food and other | Americas | ||||
Disaggregation of Revenue | ||||
Net sales | 215 | 222 | 627 | 609 |
Food and other | Europe | ||||
Disaggregation of Revenue | ||||
Net sales | 124 | 138 | 366 | 360 |
Food and other | Asia Pacific | ||||
Disaggregation of Revenue | ||||
Net sales | 6 | 38 | ||
Non-alcoholic beverages | ||||
Disaggregation of Revenue | ||||
Net sales | 213 | 188 | 581 | 545 |
Non-alcoholic beverages | Americas | ||||
Disaggregation of Revenue | ||||
Net sales | 149 | 128 | 415 | 362 |
Non-alcoholic beverages | Europe | ||||
Disaggregation of Revenue | ||||
Net sales | $ 64 | 54 | $ 166 | 157 |
Non-alcoholic beverages | Asia Pacific | ||||
Disaggregation of Revenue | ||||
Net sales | $ 6 | $ 26 |
Credit Losses (Details)
Credit Losses (Details) - USD ($) $ in Millions | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
Credit Losses | |||
Accounts receivable, net | $ 793 | $ 623 | $ 724 |
Allowance for doubtful accounts | $ 31 | $ 33 | $ 33 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Millions | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
Inventories | |||
Finished goods | $ 651 | $ 675 | $ 625 |
Raw materials | 120 | 129 | 121 |
Operating supplies | 37 | 37 | 36 |
Inventories | $ 808 | $ 841 | $ 782 |
Derivative Instruments - Deriva
Derivative Instruments - Derivatives and Hedges (Details) - Cash Flow Hedges - USD ($) $ in Millions | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
Foreign exchange risk | |||
Derivatives and Hedges | |||
Unrecognized (loss) gain included in Accumulated OCI | $ 9 | $ 9 | $ 9 |
Interest rate risk | |||
Derivatives and Hedges | |||
Unrecognized (loss) gain included in Accumulated OCI | $ 0 | ||
Interest rate risk | Maximum | |||
Derivatives and Hedges | |||
Unrecognized (loss) gain included in Accumulated OCI | $ (1) | $ (1) |
Derivative Instruments - Balanc
Derivative Instruments - Balance Sheet Classification (Details) € in Millions, $ in Millions | Sep. 30, 2021USD ($) | Sep. 30, 2021EUR (€) | Dec. 31, 2020USD ($) | Dec. 31, 2020EUR (€) | Sep. 30, 2020USD ($) | Sep. 30, 2020EUR (€) |
Derivatives, Fair Value | ||||||
Total asset derivatives | $ 21 | $ 25 | $ 30 | |||
Total liability derivatives | 87 | 170 | 100 | |||
Current derivative asset | 15 | 13 | 16 | |||
Current derivative liability | 4 | 15 | 13 | |||
Noncurrent derivative asset | 6 | 12 | 14 | |||
Noncurrent derivative liability | 83 | 155 | 87 | |||
Derivatives designated as hedging instruments | ||||||
Derivatives, Fair Value | ||||||
Total asset derivatives | 20 | 24 | 27 | |||
Total liability derivatives | 83 | 167 | 94 | |||
Derivatives designated as hedging instruments | Interest rate swaps - fair value hedges | ||||||
Derivatives, Fair Value | ||||||
Notional amount | € | € 725 | € 725 | € 725 | |||
Total asset derivatives | 9 | 17 | 16 | |||
Total liability derivatives | 1 | |||||
Derivatives designated as hedging instruments | Cash flow hedges of foreign exchange risk | ||||||
Derivatives, Fair Value | ||||||
Notional amount | 878 | 978 | 1,100 | |||
Total asset derivatives | 9 | 6 | 9 | |||
Total liability derivatives | 54 | 115 | 67 | |||
Derivatives designated as hedging instruments | Net investment hedges | ||||||
Derivatives, Fair Value | ||||||
Notional amount | € | € 311 | € 311 | € 311 | |||
Total asset derivatives | 2 | 1 | 2 | |||
Total liability derivatives | 28 | 52 | 27 | |||
Derivatives not designated as hedging instruments | Foreign exchange contracts | ||||||
Derivatives, Fair Value | ||||||
Notional amount | 291 | 247 | 247 | |||
Total asset derivatives | 1 | 1 | 3 | |||
Total liability derivatives | $ 4 | $ 3 | $ 6 |
Derivative Instruments - Effect
Derivative Instruments - Effects of Derivative Instruments (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Derivatives not designated as hedging instruments | Foreign exchange contracts | ||||
Derivatives and Hedges | ||||
Amount of Gain (Loss) Recognized in Other income (expense), net | $ 2 | $ 3 | $ 9 | $ 13 |
Derivatives designated as hedging instruments | ||||
Derivatives and Hedges | ||||
Gain (Loss) Recognized in OCI (Effective Portion) | 37 | (87) | 83 | (80) |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | 25 | (79) | 59 | (68) |
Derivatives designated as hedging instruments | Net Investment Hedges | Interest expense, net | ||||
Derivatives and Hedges | ||||
Gain (Loss) Recognized in OCI (Effective Portion) | 13 | (26) | 27 | (29) |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | 1 | 1 | 2 | 4 |
Derivatives designated as hedging instruments | Foreign exchange risk | Cash Flow Hedges | Other income (expense), net | ||||
Derivatives and Hedges | ||||
Gain (Loss) Recognized in OCI (Effective Portion) | 24 | (61) | 56 | (51) |
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | $ 24 | $ (80) | $ 57 | (71) |
Derivatives designated as hedging instruments | Interest rate risk | Cash Flow Hedges | Interest expense, net | ||||
Derivatives and Hedges | ||||
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | $ (1) |
Restructuring (Details)
Restructuring (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Restructuring accrual | ||||
Beginning balance, restructuring reserve | $ 44 | $ 47 | $ 45 | $ 45 |
Charges | 12 | 5 | 20 | 72 |
Write-down of assets to net realizable value | (1) | (3) | (1) | (43) |
Net cash paid, principally severance and related benefits | (5) | (10) | (14) | (32) |
Other, including foreign exchange translation | (4) | (7) | ||
Ending balance, restructuring reserve | 50 | 35 | 50 | 35 |
Restructuring, Additional Information | ||||
Carrying value of impaired assets | 1 | 1 | ||
Employee Costs | ||||
Restructuring accrual | ||||
Beginning balance, restructuring reserve | 32 | 30 | 38 | 32 |
Charges | 2 | 2 | 23 | |
Net cash paid, principally severance and related benefits | (4) | (10) | (11) | (31) |
Other, including foreign exchange translation | (1) | (2) | ||
Ending balance, restructuring reserve | 28 | 22 | 28 | 22 |
Asset Impairment | ||||
Restructuring accrual | ||||
Charges | 1 | 3 | 1 | 43 |
Write-down of assets to net realizable value | (1) | (3) | (1) | (43) |
Other Exit Costs | ||||
Restructuring accrual | ||||
Beginning balance, restructuring reserve | 12 | 17 | 7 | 13 |
Charges | 11 | 17 | 6 | |
Net cash paid, principally severance and related benefits | (1) | (3) | (1) | |
Other, including foreign exchange translation | (4) | 1 | (5) | |
Ending balance, restructuring reserve | $ 22 | $ 13 | $ 22 | $ 13 |
Pension Benefit Plans (Details)
Pension Benefit Plans (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Pension Benefit Plans | ||||
Amortization: | ||||
Settlements | $ 5 | $ 0 | $ 5 | $ 8 |
Decrease in benefit liability | 46 | 46 | ||
Postretirement Benefits Other Than Pensions | U.S. | ||||
Amortization: | ||||
Decrease in benefit liability | 32 | |||
Funded Plan | Pension Benefit Plans | U.S. | ||||
Components of net periodic pension cost | ||||
Service cost | 3 | 3 | 9 | 9 |
Interest cost | 10 | 12 | 30 | 37 |
Expected asset return | (21) | (19) | (63) | (60) |
Amortization: | ||||
Amortization of actuarial loss | 16 | 14 | 48 | 42 |
Net periodic pension cost | 8 | 10 | 24 | 28 |
Funded Plan | Pension Benefit Plans | Non-U.S. Pension Plans | ||||
Components of net periodic pension cost | ||||
Service cost | 3 | 3 | 9 | 10 |
Interest cost | 5 | 6 | 15 | 19 |
Expected asset return | (11) | (12) | (34) | (36) |
Amortization: | ||||
Amortization of actuarial loss | $ 3 | $ 3 | $ 10 | 9 |
Net periodic pension cost | $ 2 |
Income Taxes (Details)
Income Taxes (Details) | 9 Months Ended |
Sep. 30, 2021 | |
Income Taxes. | |
Statutory U.S. Federal tax rate (as a percent) | 21.00% |
Debt (Details)
Debt (Details) $ / shares in Units, € in Millions, $ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||||||
Aug. 31, 2020USD ($) | May 31, 2020USD ($) | Dec. 31, 2021 | Sep. 30, 2021USD ($)$ / shares | Sep. 30, 2021USD ($)agreement$ / shares | Sep. 30, 2021EUR (€) | Dec. 31, 2020USD ($) | Dec. 31, 2020EUR (€) | Sep. 30, 2020USD ($) | Sep. 30, 2020EUR (€) | |
Debt Instrument | ||||||||||
Total long-term debt | $ 4,890 | $ 4,890 | $ 5,087 | $ 5,296 | ||||||
Less amounts due within one year | 37 | 37 | 142 | 133 | ||||||
Long-term debt | $ 4,853 | $ 4,853 | 4,945 | 5,163 | ||||||
Number of financial maintenance covenants | agreement | 1 | |||||||||
Maximum Leverage Ratio may increase | 0.5 | |||||||||
Maximum | ||||||||||
Debt Instrument | ||||||||||
Leverage Ratio | 4.75 | 5 | ||||||||
Maximum Borrowing Capacity | $ 3,000 | $ 3,000 | ||||||||
Maximum | Forecast | ||||||||||
Debt Instrument | ||||||||||
Leverage Ratio | 4.50 | |||||||||
Secured Credit Agreement | ||||||||||
Debt Instrument | ||||||||||
Unused Credit | $ 1,489 | $ 1,489 | ||||||||
Weighted average interest rate (as a percent) | 1.58% | 1.58% | 1.58% | |||||||
Secured Credit Agreement | Minimum | ||||||||||
Debt Instrument | ||||||||||
Interest rate margin, Eurocurrency Rate loans (as a percent) | 1.00% | 1.00% | 1.00% | |||||||
Interest rate margin, Base Rate loans (as a percent) | 0.00% | |||||||||
Secured Credit Agreement | Maximum | ||||||||||
Debt Instrument | ||||||||||
Interest rate margin, Eurocurrency Rate loans (as a percent) | 1.50% | 1.50% | 1.50% | |||||||
Interest rate margin, Base Rate loans (as a percent) | 0.50% | |||||||||
Revolving Loans | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | 195 | |||||||||
Term Loan A | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 1,068 | $ 1,068 | 1,067 | 1,157 | ||||||
Face Value | 1,500 | 1,500 | ||||||||
Increase in long term debt, net of debt issuance costs | 1,068 | |||||||||
Other secured debt | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | 99 | 109 | ||||||||
Debt redeemed | $ 105 | |||||||||
Senior Notes | ||||||||||
Debt Instrument | ||||||||||
Additional interest charges for note repurchase premiums and write-off of unamortized finance fees | $ 38 | |||||||||
Senior Notes 4.875%, due 2021 (330 million EUR) | ||||||||||
Debt Instrument | ||||||||||
Interest rate, stated percentage | 4.875% | |||||||||
Debt redeemed | $ 130 | |||||||||
Senior Notes 5.00%, due 2022 | ||||||||||
Debt Instrument | ||||||||||
Interest rate, stated percentage | 5.00% | 5.00% | ||||||||
Debt redeemed | $ 81 | $ 419 | ||||||||
Additional interest charges for note repurchase premiums and write-off of unamortized finance fees | $ 6 | |||||||||
Senior Notes 4.00%, due 2023 | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 308 | $ 308 | 307 | 307 | ||||||
Interest rate, stated percentage | 4.00% | 4.00% | 4.00% | |||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 310 | $ 310 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 102.57 | $ 102.57 | ||||||||
Fair Value | $ 318 | $ 318 | ||||||||
Senior Notes 5.875%, due 2023 | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 694 | $ 694 | 692 | 691 | ||||||
Interest rate, stated percentage | 5.875% | 5.875% | 5.875% | |||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 700 | $ 700 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 106 | $ 106 | ||||||||
Fair Value | $ 742 | $ 742 | ||||||||
Senior Notes 3.125%, due 2024 (725 million EUR) | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 854 | $ 854 | € 725 | 914 | € 725 | 873 | € 725 | |||
Interest rate, stated percentage | 3.125% | 3.125% | 3.125% | |||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 841 | $ 841 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 103.53 | $ 103.53 | ||||||||
Fair Value | $ 871 | $ 871 | ||||||||
Senior Notes 6.375%, due 2025 | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 297 | $ 297 | 296 | 296 | ||||||
Interest rate, stated percentage | 6.375% | 6.375% | 6.375% | |||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 300 | $ 300 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 110.86 | $ 110.86 | ||||||||
Fair Value | $ 333 | $ 333 | ||||||||
Senior Notes, 5.375% due 2025 | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 298 | $ 298 | 298 | 298 | ||||||
Interest rate, stated percentage | 5.375% | 5.375% | 5.375% | |||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 300 | $ 300 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 107.11 | $ 107.11 | ||||||||
Fair Value | $ 321 | $ 321 | ||||||||
Senior Notes 2.875%, due 2025 (500 million EUR) | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 574 | $ 574 | € 500 | 607 | € 500 | 579 | € 500 | |||
Interest rate, stated percentage | 2.875% | 2.875% | 2.875% | |||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 580 | $ 580 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 101.56 | $ 101.56 | ||||||||
Fair Value | $ 589 | $ 589 | ||||||||
Senior Notes 6.625%, due 2027 | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 700 | $ 693 | $ 693 | 692 | 691 | |||||
Interest rate, stated percentage | 6.625% | 6.625% | 6.625% | 6.625% | ||||||
Increase in long term debt, net of debt issuance costs | $ 690 | |||||||||
Fair values of fixed rate debt obligations | ||||||||||
Principal Amount | $ 700 | $ 700 | ||||||||
Indicated Market Price (in dollars per share) | $ / shares | $ 107.40 | $ 107.40 | ||||||||
Fair Value | $ 752 | $ 752 | ||||||||
Finance leases | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | 99 | 99 | 108 | 94 | ||||||
Other debt | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | 5 | 5 | $ 7 | $ 6 | ||||||
Revolving Credit Facility | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | 300 | $ 300 | ||||||||
Additional default interest rate per annum applied to all obligations owed under the Agreement | 2.00% | |||||||||
Revolving Credit Facility | Minimum | ||||||||||
Debt Instrument | ||||||||||
Facility fee payable (as a percent) | 0.20% | |||||||||
Revolving Credit Facility | Maximum | ||||||||||
Debt Instrument | ||||||||||
Facility fee payable (as a percent) | 0.30% | |||||||||
Multicurrency Revolving Credit Facility | ||||||||||
Debt Instrument | ||||||||||
Total long-term debt | $ 1,200 | $ 1,200 |
Contingencies - Asbestos (Detai
Contingencies - Asbestos (Details) | Apr. 26, 2021USD ($) | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Sep. 30, 2021USD ($)lawsuit | Sep. 30, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 1993USD ($) |
Contingencies | ||||||||
Sale of goods containing asbestos from 1948 to 1958 | $ 40,000,000 | |||||||
Cash | $ 47,000,000 | |||||||
Number of pending plaintiffs and claimants | lawsuit | 850 | |||||||
Approximate number of claims disposed | lawsuit | 401,200 | |||||||
Average indemnity payment per claim | $ 10,200 | |||||||
Asbestos-related cash payments | $ 151,000,000 | |||||||
Cash payments per claim disposed including legal costs | 129,000 | |||||||
Asbestos-related liability, total amount accrued beginning in 1993 through current reporting period before insurance recoveries | 5,000,000,000 | $ 975,000,000 | ||||||
Accrual of asbestos related liability | 486,000,000 | |||||||
Asbestos related charges | $ 35,000,000 | |||||||
Settlement Consideration | $ 610,000,000 | |||||||
Percentage of current asbestos claimants voting on the Plan | 75.00% | |||||||
Charge related to Paddock support agreement | $ 154,000,000 | 154,000,000 | ||||||
Liability from deconsolidation | $ 625,000,000 | $ 471,000,000 | $ 471,000,000 | |||||
Loss for deconsolidation of Paddock | (14,000,000) | (14,000,000) | ||||||
Deconsolidation investing outflow | $ 47,000,000 | $ 47,000,000 |
Contingencies - Other Matters (
Contingencies - Other Matters (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | 9 Months Ended | |
Jun. 30, 2021 | Sep. 30, 2021 | Sep. 30, 2021 | Mar. 31, 2021 | |
Contingencies | ||||
Loss contingency accrual | $ 11 | $ 11 | $ 20 | |
Loss contingency payment | 3 | |||
Loss contingency accrual decrease | $ (6) | |||
Gain from favorable court ruling | $ 69 | $ 69 | ||
Income tax expense related to litigation settlement | $ 28 |
Share Owners' Equity - Rollforw
Share Owners' Equity - Rollforward (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Increase (Decrease) in Share Owners' Equity | ||||
Balance | $ 502 | $ 42 | $ 401 | $ 564 |
Issuance of common stock | 1 | |||
Reissuance of common stock | 3 | 2 | 7 | 7 |
Shares repurchased | (10) | (30) | ||
Stock compensation | 3 | 3 | 11 | 8 |
Net earnings | 91 | 335 | 123 | 289 |
Other comprehensive income (loss) | (19) | (117) | 60 | (592) |
Dividends declared | (8) | |||
Other | (3) | (3) | ||
Balance | 570 | 265 | 570 | 265 |
Common Stock | ||||
Increase (Decrease) in Share Owners' Equity | ||||
Balance | 2 | 2 | 2 | 2 |
Balance | 2 | 2 | 2 | 2 |
Capital in Excess of Par Value | ||||
Increase (Decrease) in Share Owners' Equity | ||||
Balance | 3,113 | 3,128 | 3,129 | 3,130 |
Issuance of common stock | 1 | |||
Reissuance of common stock | (1) | (3) | (4) | (10) |
Shares repurchased | (10) | (30) | ||
Stock compensation | 3 | 3 | 11 | 8 |
Other | (2) | |||
Balance | 3,105 | 3,128 | 3,105 | 3,128 |
Treasury Stock | ||||
Increase (Decrease) in Share Owners' Equity | ||||
Balance | (709) | (724) | (714) | (733) |
Reissuance of common stock | 4 | 5 | 11 | 17 |
Other | (2) | (3) | ||
Balance | (705) | (719) | (705) | (719) |
Retained Earnings (Loss) | ||||
Increase (Decrease) in Share Owners' Equity | ||||
Balance | 173 | (147) | 152 | (89) |
Net earnings | 85 | 328 | 106 | 278 |
Dividends declared | (8) | |||
Balance | 258 | 181 | 258 | 181 |
Accumulated Other Comprehensive Loss | ||||
Increase (Decrease) in Share Owners' Equity | ||||
Balance | (2,180) | (2,308) | (2,272) | (1,843) |
Other comprehensive income (loss) | (18) | (117) | 74 | (582) |
Balance | (2,198) | (2,425) | (2,198) | (2,425) |
Non-controlling Interests | ||||
Increase (Decrease) in Share Owners' Equity | ||||
Balance | 103 | 91 | 104 | 97 |
Net earnings | 6 | 7 | 17 | 11 |
Other comprehensive income (loss) | (1) | (14) | (10) | |
Other | 1 | |||
Balance | $ 108 | $ 98 | $ 108 | $ 98 |
Share Owners' Equity - Rollfo_2
Share Owners' Equity - Rollforward Shares (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Increase (Decrease) in Share Owners' Equity | ||||
Issuance of common stock (in shares) | 50,000 | |||
Reissuance of common stock (in shares) | 200,000 | 200,000 | 300,000 | 700,000 |
Shares repurchased (in shares) | 619,666 | 1,000,000 | ||
Stock compensation (in shares) | 0 | 100,000 | 600,000 | 900,000 |
Share Owners' Equity - Share Re
Share Owners' Equity - Share Repurchase (Details) $ in Millions | 3 Months Ended | 9 Months Ended |
Sep. 30, 2021USD ($)shares | Sep. 30, 2021USD ($)shares | |
Share Owners' Equity | ||
Shares repurchased | $ 10 | $ 30 |
Shares repurchased (in shares) | shares | 619,666 | 1,000,000 |
Stock repurchase plan authorized | $ 150 | $ 150 |
Remaining repurchase of common stock available | $ 120 | $ 120 |
Share Owners' Equity -Authoriza
Share Owners' Equity -Authorization of Common Stock (Details) - $ / shares | Sep. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 |
Authorization of common stock | |||
Shares of common stock issued (including treasury shares) | 250,000,000 | 250,000,000 | 250,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 |
Shares of common stock issued (including treasury shares) | 188,426,000 | 189,305,000 | 189,302,000 |
Treasury shares | 31,599,000 | 31,911,000 | 32,136,000 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Other comprehensive income (loss) | $ (19) | $ (117) | $ 60 | $ (592) |
Net Effect of Exchange Rate Fluctuations | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Balance at beginning of the period | (1,187) | (1,321) | (1,229) | (813) |
Change before reclassifications | (109) | 1 | (67) | (507) |
Other comprehensive income (loss) | (109) | (148) | (67) | (656) |
Balance at end of the period | (1,296) | (1,469) | (1,296) | (1,469) |
Change in Certain Derivative Instruments | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Balance at beginning of the period | (47) | (21) | (60) | (14) |
Change before reclassifications | 37 | (88) | 83 | (81) |
Amounts reclassified from accumulated other comprehensive income (loss) | (25) | 78 | (59) | 67 |
Translation effect | (1) | 1 | (3) | |
Tax effect | 1 | (1) | 1 | (2) |
Other comprehensive income (loss) | 13 | (11) | 26 | (18) |
Balance at end of the period | (34) | (32) | (34) | (32) |
Employee Benefit Plans | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Balance at beginning of the period | (946) | (966) | (983) | (1,016) |
Change before reclassifications | 47 | 30 | 45 | 27 |
Amounts reclassified from accumulated other comprehensive income (loss) | 24 | 17 | 63 | 59 |
Translation effect | 7 | (9) | 7 | 4 |
Tax effect | (2) | |||
Other comprehensive income (loss) | 78 | 42 | 115 | 92 |
Balance at end of the period | (868) | (924) | (868) | (924) |
Accumulated Other Comprehensive Loss | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Balance at beginning of the period | (2,180) | (2,308) | (2,272) | (1,843) |
Change before reclassifications | (25) | (57) | 61 | (561) |
Amounts reclassified from accumulated other comprehensive income (loss) | (1) | 95 | 4 | 126 |
Translation effect | 7 | (10) | 8 | 1 |
Tax effect | 1 | (1) | 1 | (4) |
Other comprehensive income (loss) | (18) | (117) | 74 | (582) |
Balance at end of the period | $ (2,198) | (2,425) | $ (2,198) | (2,425) |
Australia And New Zealand ("ANZ") business | Net Effect of Exchange Rate Fluctuations | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Amounts reclassified from accumulated other comprehensive income (loss) | (149) | (149) | ||
Australia And New Zealand ("ANZ") business | Change in Certain Derivative Instruments | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Amounts reclassified from accumulated other comprehensive income (loss) | 1 | 1 | ||
Australia And New Zealand ("ANZ") business | Employee Benefit Plans | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Amounts reclassified from accumulated other comprehensive income (loss) | 4 | 4 | ||
Australia And New Zealand ("ANZ") business | Accumulated Other Comprehensive Loss | ||||
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax | ||||
Amounts reclassified from accumulated other comprehensive income (loss) | $ (144) | $ (144) |
Other Income (Expense), Net (De
Other Income (Expense), Net (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||||
Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Other Income (Expense), Net | |||||||
Gain on sale of ANZ businesses | $ 280 | $ 280 | |||||
Restructuring, asset impairment and other charges | $ (12) | (9) | $ (21) | (80) | |||
Brazil indirect tax credit | $ 69 | 69 | |||||
Pension settlement charges | (5) | (5) | (8) | ||||
Charge related to Paddock support agreement liability (see Note 10) | $ (154) | (154) | |||||
Intangible amortization expense | (9) | (8) | (26) | (23) | |||
Strategic transaction costs | (3) | (7) | |||||
Foreign currency exchange loss | (1) | (1) | (3) | (3) | |||
Royalty income | 6 | 2 | 17 | 8 | |||
Charge for deconsolidation of Paddock (see Note 10) | $ (14) | (14) | |||||
Other income, net | (11) | (6) | |||||
Other expense, net | $ (21) | $ 250 | $ (123) | $ 147 |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Numerator: | ||||
Net earnings attributable to the Company | $ 85 | $ 328 | $ 106 | $ 278 |
Denominator (in thousands): | ||||
Denominator for basic earnings per share - weighted average shares outstanding (in shares) | 156,825,000 | 157,073,000 | 157,430,000 | 156,650,000 |
Effect of dilutive securities: | ||||
Stock options and other (in shares) | 3,686,000 | 2,226,000 | 3,043,000 | 1,788,000 |
Denominator for diluted earnings per share - adjusted weighted average shares outstanding (in shares) | 160,511,000 | 159,299,000 | 160,473,000 | 158,438,000 |
Basic earnings per share: | ||||
Earnings from continuing operations attributable to the Company (in dollars per share) | $ 0.49 | $ 2.09 | $ 0.62 | $ 1.77 |
Gain from discontinued operations (in dollars per share) | 0.05 | 0.05 | ||
Net earnings | 0.54 | 2.09 | 0.67 | 1.77 |
Diluted earnings per share: | ||||
Net earnings (loss) attributable to the Company (in dollars per share) | 0.48 | 2.06 | 0.61 | 1.76 |
Gain from discontinued operations (in dollars per share) | 0.05 | 0.05 | ||
Net earnings | $ 0.53 | $ 2.06 | $ 0.66 | $ 1.76 |
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares) | 958,014 | 1,564,207 | 1,206,870 | 2,616,538 |
Supplemental Cash Flow Inform_3
Supplemental Cash Flow Information (Details) - USD ($) $ in Millions | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2020 | |
Supplemental Cash Flow Information | |||
Amount of receivables sold | $ 416 | $ 426 | $ 436 |
Receivables sold under supply-chain factoring program | 189 | 188 | $ 176 |
Interest paid in cash | 144 | 196 | |
Change in cash from operating activities from factoring program | (20) | (113) | |
Income taxes paid in cash | |||
Income taxes paid in cash | 64 | 54 | |
Interest paid for note repurchase premiums related to debt repaid prior to maturity | 41 | ||
U.S. operations | |||
Income taxes paid in cash | |||
Income taxes paid in cash | 6 | 1 | |
Non-U.S. | |||
Income taxes paid in cash | |||
Income taxes paid in cash | $ 58 | $ 53 |
Divestitures (Details)
Divestitures (Details) $ in Millions, $ in Millions | Jul. 31, 2020USD ($) | Jul. 31, 2020AUD ($) | Jan. 31, 2021USD ($) | Mar. 31, 2021USD ($) | Sep. 30, 2020USD ($) | Sep. 30, 2020USD ($) | Dec. 31, 2020USD ($) |
Divestiture | |||||||
Gain on sale of businesses | $ 280 | $ 280 | |||||
Argentina | Discontinued Operations, Disposed of by Sale | |||||||
Divestiture | |||||||
Gross proceeds | $ 10 | ||||||
Australia And New Zealand ("ANZ") business | Discontinued Operations, Disposed of by Sale | |||||||
Divestiture | |||||||
Gross proceeds | $ 677 | $ 947 | $ 58 | ||||
Sale and related sale lease-back net proceeds | $ 214 | ||||||
Percentage of proceeds were received at time of closing | 95.00% | 95.00% | |||||
Australia And New Zealand ("ANZ") business | Other operating income (expense) | Discontinued Operations, Disposed of by Sale | |||||||
Divestiture | |||||||
Gain on sale of businesses | $ 275 |
Subsequent Event (Details)
Subsequent Event (Details) - Subsequent Event - Le Parfait - Disposal Group, Disposed of by Sale, Not Discontinued Operations € in Millions | Oct. 25, 2021EUR (€)country |
Subsequent Events | |
Proceeds from sale of businesses | € | € 72 |
Minimum | |
Subsequent Events | |
Number of countries in which product is sold | country | 20 |